<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Front Chem</journal-id><journal-id journal-id-type="iso-abbrev">Front Chem</journal-id><journal-id journal-id-type="publisher-id">Front. Chem.</journal-id><journal-title-group><journal-title>Frontiers in Chemistry</journal-title></journal-title-group><issn pub-type="epub">2296-2646</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38974993</article-id><article-id pub-id-type="pmc">11224555</article-id><article-id pub-id-type="publisher-id">1424157</article-id><article-id pub-id-type="doi">10.3389/fchem.2024.1424157</article-id><article-categories><subj-group subj-group-type="heading"><subject>Chemistry</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>New synthesis of oligosaccharides modelling the M epitope of the <italic>Brucella</italic> O-polysaccharide</article-title><alt-title alt-title-type="left-running-head">Tsvetkov et al.</alt-title><alt-title alt-title-type="right-running-head">
<ext-link xlink:href="https://doi.org/10.3389/fchem.2024.1424157" ext-link-type="uri">10.3389/fchem.2024.1424157</ext-link>
</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tsvetkov</surname><given-names>Yury E.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1135737/overview"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Volkov</surname><given-names>Timur M.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Eremin</surname><given-names>Sergei A.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/570473/overview"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Sklyarov</surname><given-names>Oleg D.</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/></contrib><contrib contrib-type="author"><name><surname>Kulakov</surname><given-names>Yuri K.</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Krylov</surname><given-names>Vadim B.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1444433/overview"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Nifantiev</surname><given-names>Nikolay E.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/355038/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Laboratory of Glycoconjugate Chemistry</institution>, <institution>N.D. Zelinsky Institute of Organic Chemistry</institution>, <institution>Russian Academy of Sciences</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Faculty of Chemistry</institution>, <institution>M.V. Lomonosov Moscow State University</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>Russian State Centre of Quality and Standardization of Veterinary Drugs and Feeds</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Laboratory of Brucellosis</institution>, <institution>N.F.Gamaleya National Research Center of Epidemiology and Microbiology</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Laboratory of Synthetic Glycovaccines</institution>, <institution>N.D. Zelinsky Institute of Organic Chemistry</institution>, <institution>Russian Academy of Sciences</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/60186/overview" ext-link-type="uri">Steve Suib</ext-link>, University of Connecticut, United States</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/661978/overview" ext-link-type="uri">Maria Rosaria Romano</ext-link>, GlaxoSmithKline, Italy</p><p>
<ext-link xlink:href="https://loop.frontiersin.org/people/1199187/overview" ext-link-type="uri">Roberto Adamo</ext-link>, GlaxoSmithKline, Italy</p></fn><corresp id="c001">*Correspondence: Nikolay E. Nifantiev, <email>nen@ioc.ac.ru</email>
</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>12</volume><elocation-id>1424157</elocation-id><history><date date-type="received"><day>27</day><month>4</month><year>2024</year></date><date date-type="accepted"><day>30</day><month>5</month><year>2024</year></date></history><permissions><copyright-statement>Copyright &#xA9; 2024 Tsvetkov, Volkov, Eremin, Sklyarov, Kulakov, Krylov and Nifantiev.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Tsvetkov, Volkov, Eremin, Sklyarov, Kulakov, Krylov and Nifantiev</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Brucellosis is a dangerous zoonotic disease caused by bacteria of the genus <italic>Brucella</italic>. Diagnosis of brucellosis is based on the detection in animal and human sera of antibodies to the O-polysaccharide of <italic>Brucella</italic> lipopolysaccharide. The currently employed serodiagnosis of brucellosis relies on the use of the <italic>Brucella</italic> O-polysaccharide as a diagnostic antigen. However, the existence of bacterial species, which also express O-polysaccharides structurally similar to that of <italic>Brucella</italic>, may decrease the specificity of the brucellosis detection due to false-positive test results. It has been shown that the efficiency of the test can be significantly improved by using synthetic oligosaccharides that correspond to the so-called M epitope of the <italic>Brucella</italic> O-antigen. This epitope is characterized by an &#x3B1;-(1&#x2192;3)-linkage between <sc>d</sc>-perosamine units and is unique to <italic>Brucella</italic>. Here we report on an efficient approach to the synthesis of oligosaccharides that model the M epitope of the <italic>Brucella</italic> O-polysaccharide. The approach is based on the use of the &#x3B1;-(1&#x2192;3)-linked disaccharide thioglycoside as the key donor block. Its application allowed the straightforward assembly of a set of four protected oligosaccharides, which includes a disaccharide, two trisaccharides, and a tetrasaccharide, in five glycosylation steps. The synthesized oligosaccharides are planned to be used in the development of diagnostic tools for identifying brucellosis in humans and domestic animals, as well as a potential vaccine against it.</p></abstract><kwd-group><kwd><italic>Brucella</italic></kwd><kwd>lipopolysaccharide</kwd><kwd>O-polysaccharide</kwd><kwd>M epitope</kwd><kwd>4-formamido</kwd><kwd>4,6-dideoxy-D-mannose</kwd><kwd>oligosaccharides</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Russian Science Foundation (Grant 19-73-30017-P).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Organic Chemistry</meta-value></custom-meta></custom-meta-group></article-meta></front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Brucellosis is a bacterial infection of domestic animals, including cattle, sheep, goats, pigs and others. It is caused by Gram-negative bacteria of the genus <italic>Brucella</italic>. The disease can lead to abortions, infertility, weight loss, and reduced productivity in infected animals. When humans come into contact with infected animals or their products, such as milk, contaminated meat or organs, they can become infected with brucellosis. This can lead to serious acute and chronic illness with non-specific symptoms similar to malaria or influenza, and is therefore a significant public health concern (<xref rid="B8" ref-type="bibr">Franco et al., 2007</xref>).</p>
      <p>One of the main virulence factors of <italic>Brucella</italic> is a lipopolysaccharide (LPS), which is located on the surface of the bacterial cell. The lipid part of LPS is embedded in the cell membrane, while the polysaccharide component (O-polysaccharide) extends outwards into the external environment, and thus determines the immunologic properties of the bacterium. O-Polysaccharide is a homopolymer of N-formylated 4-amino-4,6-dideoxy-<sc>d</sc>-mannose, also known as <sc>d</sc>-perosamine. N-Formyl-<sc>d</sc>-perosamine forms an &#x3B1;-(1&#x2192;2)-linked linear chain terminated with one or more tetrasaccharide units that contain two &#x3B1;-(1&#x2192;2)- and one central &#x3B1;-(1&#x2192;3)-glycosidic bonds (<xref rid="F1" ref-type="fig">Figure 1</xref>) (<xref rid="B19" ref-type="bibr">Kubler-Kielb and Vinogradov, 2013</xref>). The O-polysaccharide chain has a relatively low molecular weight, with a maximum of 25&#x2013;30 monosaccharide units (<xref rid="B19" ref-type="bibr">Kubler-Kielb and Vinogradov, 2013</xref>). The antigenic determinants, represented by the &#x3B1;-(1&#x2192;2)-linked chain and the terminal tetrasaccharide with the &#x3B1;-(1&#x2192;3)-bond, are referred to as the A epitope (prevails in most strains of B. <bold>a</bold>bortus) and the M epitope (is characteristic of B. <bold>m</bold>elitensis), respectively.</p>
      <fig position="float" id="F1">
        <label>FIGURE 1</label>
        <caption>
          <p>Structure of the O-polysaccharide of <italic>Brucella</italic> and the O-polysaccharides of other bacteria comprising N-acyl-<sc>d</sc>-perosamine.</p>
        </caption>
        <graphic xlink:href="fchem-12-1424157-g001" position="float"/>
      </fig>
      <p>The detection of antibodies specific to the O-polysaccharide in animal and human sera is the basis for the diagnosis of brucellosis (<xref rid="B26" ref-type="bibr">Nielsen, 2002</xref>; <xref rid="B11" ref-type="bibr">Godfroid et al., 2010</xref>). However, this biopolymer is not readily available through bacterial cultivation. Although the chemical synthesis of polysaccharides is in principal possible (<xref rid="B16" ref-type="bibr">Kochetkov et al., 1987</xref>; <xref rid="B32" ref-type="bibr">Tsvetkov et al., 1989</xref>), this task is often too complex. It is important that the specificity of the serodiagnosis using <italic>Brucella</italic> O-polysaccharide as a diagnostic antigen may not be high enough, as there are some bacteria that have O-polysaccharides made up of N-acylated <sc>d</sc>-perosamine. A prominent example of these bacteria is <italic>Yersinia enterocolitica</italic> O:9. Its O-polysaccharide consists of &#x3B1;-(1&#x2192;2)-linked N-formyl-<sc>d</sc>-perosamine units only (<xref rid="B6" ref-type="bibr">Caroff et al., 1984</xref>), and is structurally identical to the A epitope of <italic>Brucella</italic>. Another example is <italic>Escherichia coli</italic> O157, whose O-polysaccharide contains &#x3B1;-(1&#x2192;2)-linked N-acetyl-<sc>d</sc>-perosamine (<xref rid="B27" ref-type="bibr">Perry and Bundle, 1990</xref>). Sera obtained from animals or humans infected with such bacteria may contain antibodies that cross-react with the <italic>Brucella</italic> O-polysaccharide, leading to false-positive test results.</p>
      <p>An increase in the specificity of the serodiagnosis of brucellosis can be achieved through the use of antigens related to the epitope M, which is unique to <italic>Brucella</italic> and is absent in the O-polysaccharides of other bacteria. It is evident that obtaining such antigens from the natural O-polysaccharide is challenging, if not impossible, and the most promising way to produce them is through chemical synthesis. Nowadays, synthetic oligosaccharides of virtually any structure are accessible and find application in immunological studies, including the development of diagnostic tools and vaccines, as a good alternative for antigenic polysaccharides (for recent examples see <xref rid="B1" ref-type="bibr">Argunov et al., 2015</xref>; <xref rid="B10" ref-type="bibr">Gening et al., 2015</xref>; <xref rid="B15" ref-type="bibr">Kazakova et al., 2020</xref>; <xref rid="B17" ref-type="bibr">Komarova et al., 2018</xref>; <xref rid="B18" ref-type="bibr">Krylov et al., 2019</xref>; <xref rid="B20" ref-type="bibr">Laverde et al., 2020</xref>; <xref rid="B30" ref-type="bibr">Solovev et al., 2023</xref>; <xref rid="B34" ref-type="bibr">Wong et al., 2020</xref>).</p>
      <p>The use of synthetic oligosaccharides that mimic the M epitope of the <italic>Brucella</italic> O-polysaccharide for serodiagnosis has recently been investigated by Bundle et al. A large group of oligosaccharides with the characteristic for the M epitope (1&#x2192;3)-glycoside bond between N-formyl-<sc>d</sc>-perosamine residues, was synthesized (<xref rid="B13" ref-type="bibr">Guiard et al., 2013</xref>; <xref rid="B9" ref-type="bibr">Ganesh et al., 2014</xref>; <xref rid="B5" ref-type="bibr">Bundle and McGiven, 2017</xref>). BSA conjugates of these synthetic oligosaccharides, particularly the (1&#x2192;3)-linked disaccharide and the tetrasaccharide with the central (1&#x2192;3)-glycoside bond, have shown high diagnostic sensitivity and specificity, as well as the ability to reliably differentiate between the sera of infected animals and those that give false-positive results when tested using conventional methods (<xref rid="B23" ref-type="bibr">McGiven et al., 2015</xref>; <xref rid="B5" ref-type="bibr">Bundle and McGiven, 2017</xref>).</p>
      <p>However, the use of BSA as a carrier protein may carry risks of obtaining overestimated results. This is due to the presence in human sera of antibodies capable of recognizing BSA (<xref rid="B24" ref-type="bibr">Mogues et al., 2005</xref>; <xref rid="B29" ref-type="bibr">Sj&#xF6;wall et al., 2011</xref>) and false-positive signals caused by multimeric presentation of glycoligands in the BSA conjugates (<xref rid="B12" ref-type="bibr">Grant et al., 2014</xref>; <xref rid="B31" ref-type="bibr">Temme et al., 2019</xref>). In addition, there may be a risk of non-specific interactions with hydrophobic spacers, for example, the 5-carboxypentyl spacer used in the works by Bundle et al. (<xref rid="B13" ref-type="bibr">Guiard et al., 2013</xref>; <xref rid="B9" ref-type="bibr">Ganesh et al., 2014</xref>; <xref rid="B21" ref-type="bibr">Mandal et al., 2017a</xref>; <xref rid="B22" ref-type="bibr">Mandal et al., 2017b</xref>; <xref rid="B5" ref-type="bibr">Bundle and McGiven, 2017</xref>).</p>
      <p>&#x3B1;-(1&#x2192;2)-Linked oligomers of N-(3-deoxy-L-<italic>glycero</italic>-tetronoyl)-D-perosamine related to the O-polysaccharide of <italic>Vibrio cholerae</italic> O1 have been synthesized by the Kov&#xE1;&#x107;&#x2019;s group (<xref rid="B14" ref-type="bibr">Hou and Kova&#x10D;, 2010</xref>; <xref rid="B25" ref-type="bibr">Mukherjee et al., 2019</xref>). Recently, we reported the synthesis of the (1&#x2192;3)-linked disaccharide <bold>4</bold> (<xref rid="F2" ref-type="fig">Figure 2</xref>) (<xref rid="B33" ref-type="bibr">Tsvetkov and Nifantiev, 2023</xref>), which corresponds to the unique structural element of the M epitope of the <italic>Brucella</italic> O-polysaccharide. Here, we report on the synthesis of larger oligosaccharides <bold>1</bold>-<bold>3</bold> that comprise the (1&#x2192;3)-linked disaccharide as a fragment. They were prepared with the aim of developing fluorescence polarization&#x2013;based and other types of diagnostic assays to identify brucellosis in animals and humans and as potential ligands for the design of corresponding vaccines. Additionally, pentasaccharide <bold>6</bold> has been synthesized, representing tetrasaccharide <bold>1</bold> devoid of terminal unsubstituted <sc>d</sc>-perosamine through its capping with a <sc>d</sc>-rhamnose residue. We have also prepared monosaccharide <bold>5</bold>, as it has been reported that sera from mice immunized with conjugate immunogens based on (1&#x2192;2)-linked <italic>Brucella</italic> oligosaccharides and sera from naturally Brucella-infected cattle contained high titers of antibodies specific to the terminal <sc>d</sc>-perosamine unit (<xref rid="B21" ref-type="bibr">Mandal et al., 2017a</xref>; <xref rid="B7" ref-type="bibr">Duncombe et al., 2022</xref>). The synthesized compounds were equipped with a short 3-aminipropyl spacer group, which was thought to be less hydrophobic than the 5-carboxypentyl group used by Bundle et al. We hypothesized that the use of the 3-aminopropyl spacer would minimize hydrophobic interactions, which could interfere with antigen-antibody recognition processes.</p>
      <fig position="float" id="F2">
        <label>FIGURE 2</label>
        <caption>
          <p>Oligosaccharides synthesized in this work.</p>
        </caption>
        <graphic xlink:href="fchem-12-1424157-g002" position="float"/>
      </fig>
    </sec>
    <sec sec-type="results|discussion" id="s2">
      <title>Results and discussion</title>
      <p>Oligosaccharides <bold>1</bold>-<bold>4</bold> were synthesized using a disaccharide (1&#x2192;3)-linked glycosyl donor <bold>15</bold> as the key synthetic block. This choice of the donor allowed the assembly of all four oligosaccharides in a straightforward manner. The synthesis of monosaccharide derivatives, which were used as glycosyl acceptors in the preparation of the target structures, is shown in <xref rid="sch1" ref-type="fig">Scheme 1</xref>.</p>
      <fig position="float" id="sch1">
        <label>SCHEME 1</label>
        <caption>
          <p>Preparation of monosaccharide acceptor blocks <bold>9</bold> and <bold>13</bold>.</p>
        </caption>
        <graphic xlink:href="FCHEM_fchem-2024-1424157_wc_sch1" position="float"/>
      </fig>
      <p>Treatment of known 1,3-diacetate <bold>7</bold> (<xref rid="B22" ref-type="bibr">Mandal et al., 2017b</xref>) with 5-(<italic>tert-</italic>butyl)-2-methylthiophenol in the presence of BF<sub>3</sub>&#xB7;Et<sub>2</sub>O produced an inseparable mixture of &#x3B1;- and &#x3B2;-thioglycosides <bold>8</bold>. After conventional deacetylation of <bold>8</bold>, the anomers were separated and pure &#x3B1;-anomer <bold>9</bold> was isolated in 82% yield. Similarly, TMSOTf-promoted glycosylation of alcohol <bold>11</bold> with 1,2-diacetate <bold>10</bold> (<xref rid="B4" ref-type="bibr">Bundle et al., 1988</xref>) and subsequent deacetylation of glycoside <bold>12</bold> afforded glycosyl acceptor <bold>13</bold>.</p>
      <p>Using acceptors <bold>9</bold> and <bold>13</bold>, and the known trichloroacetimidate <bold>14</bold> (<xref rid="B2" ref-type="bibr">Ariosa-Alvarez et al., 1998</xref>) as a glycosyl donor, all oligosaccharides were assembled in five glycosylation steps (<xref rid="sch2" ref-type="fig">Scheme 2</xref>).</p>
      <fig position="float" id="sch2">
        <label>SCHEME 2</label>
        <caption>
          <p>Assembly of protected oligosaccharides <bold>16</bold>, <bold>18</bold>, <bold>20</bold>, <bold>22</bold>.</p>
        </caption>
        <graphic xlink:href="FCHEM_fchem-2024-1424157_wc_sch2" position="float"/>
      </fig>
      <p>Orthogonal glycosylation of thioglycoside acceptor <bold>9</bold> with imidate <bold>14</bold> smoothly gave key intermediate <bold>15</bold> in 88% yield. Further NIS&#x2013;TMSOTf-promoted glycosylation of acceptors <bold>11</bold> and <bold>13</bold> with thioglycoside <bold>15</bold> efficiently produced disaccharide <bold>20</bold> and trisaccharide <bold>16</bold>. The <sup>1</sup>
<italic>J</italic>
<sub>C-1,H-1</sub> coupling constant values (170&#x2013;172 Hz) for the 3-substituted monosaccharide residues in products <bold>16</bold> and <bold>20</bold> confirmed the &#x3B1;-configuration of the newly formed glycoside bonds (<xref rid="B3" ref-type="bibr">Bock and Pedersen, 1974</xref>). Despite the presence of a non-participating benzyl group at O-2, donor <bold>15</bold> ensured high &#x3B1;-stereoselectivity of glycosylation, in agreement with published data (<xref rid="B14" ref-type="bibr">Hou and Kova&#x10D;, 2010</xref>). Removal of sole acetyl groups from <bold>16</bold> and <bold>20</bold> provided glycosyl acceptors <bold>17</bold> and <bold>21</bold> almost quantitatively. Final glycosylation of these acceptors with imidate <bold>14</bold> afforded tetrasaccharide <bold>18</bold> and trisaccharide <bold>22</bold> in excellent yields. Deacetylation of <bold>18</bold> and <bold>22</bold> gave alcohols <bold>19</bold> and <bold>23</bold>. The structure of protected oligosaccharides <bold>15</bold>-<bold>23</bold> was confirmed by data of fully assigned <sup>1</sup>H and <sup>13</sup>C NMR spectra (see <xref rid="s10" ref-type="sec">Supplementary Material</xref>) and high resolution MS.</p>
      <p>Then oligosaccharides <bold>17</bold>, <bold>19</bold>, <bold>21</bold>, <bold>23</bold>, and monosaccharide <bold>13</bold> were transformed to final products <bold>1</bold>-<bold>5</bold>. The reaction sequence employed for this transformation included reduction of azide groups, N-formylation, hydrogenolytic debenzylation and removal of the N-trifluoroacetyl group. This sequence is shown in <xref rid="sch3" ref-type="fig">Scheme 3</xref> in relation to disaccharide <bold>21</bold>. Intermediate products <bold>24</bold>-<bold>26</bold> on the way from <bold>21</bold> to unprotected <bold>4</bold> were characterized by high resolution mass-spectrometry. Each of the four protected compounds <bold>13</bold>, <bold>17</bold>, <bold>19</bold>, and <bold>23</bold> was processed similarly (for details see <xref rid="s10" ref-type="sec">Supplementary Material</xref>).</p>
      <fig position="float" id="sch3">
        <label>SCHEME 3</label>
        <caption>
          <p>Synthesis of free mono-(<bold>5</bold>) and oligosaccharides (<bold>1</bold>&#x2013;<bold>4</bold>).</p>
        </caption>
        <graphic xlink:href="FCHEM_fchem-2024-1424157_wc_sch3" position="float"/>
      </fig>
      <p>As hydrogen sulfide applied by Bundle et al. for the reduction of azide moieties (<xref rid="B13" ref-type="bibr">Guiard et al., 2013</xref>; <xref rid="B9" ref-type="bibr">Ganesh et al., 2014</xref>; <xref rid="B22" ref-type="bibr">Mandal et al., 2017b</xref>; <xref rid="B5" ref-type="bibr">Bundle and McGiven, 2017</xref>) is toxic and has an unpleasant odor, we used catalytic hydrogenation over Pd(OH)<sub>2</sub>/C at this step instead. Thus, catalytic reduction of diazide <bold>21</bold> proceeded with only minor affecting benzyl protections (<xref rid="B2" ref-type="bibr">Ariosa-Alvarez et al., 1998</xref>) and provided, after chromatographic purification, diamine <bold>24</bold> in 81% yield. N-Formylation of the latter with formic anhydride generated <italic>in situ</italic> from formic acid and DCC produced bis(formamide) <bold>25</bold> (88%), which was subjected to catalytic debenzylation with the formation of triol <bold>26</bold> (92%). Final basic removal of the N-trifluoroacetyl group and purification by size-exclusion chromatography gave target 3-aminopropyl glycoside <bold>4</bold> in 87% yield.</p>
      <p>
<italic>E/Z</italic>-Isomerism of the formamido groups results in the existence of compounds <bold>1</bold>-<bold>5</bold> as mixtures of 2<sup>n</sup> isomers, where n is the number of monosaccharides in the molecule (<xref rid="B28" ref-type="bibr">Peters et al., 1990</xref>). This strongly complicated the full assignment of NMR spectra, making it virtually impossible for oligosaccharides larger than the disaccharide. Nevertheless, the NMR data of <bold>1</bold>-<bold>5</bold> provided confirmation of the presence of the main functionalities such as formyl groups, anomeric centers, the spacer moiety, etc. (see <xref rid="s10" ref-type="sec">Supplementary Material</xref>). Particularly, signals for <italic>Z</italic>- (&#x3B4;<sub>H</sub> 8.24&#x2013;8.18 ppm; &#x3B4;<sub>C</sub> 166.1, 165.8&#xA0;ppm) and <italic>E</italic>-isomers (&#x3B4;<sub>H</sub> 8.06&#x2013;7.99&#xA0;ppm; &#x3B4;<sub>C</sub> 169.0, 168.9&#xA0;ppm) of the formyl groups, four anomeric centers of the prevailing isomer (&#x3B4;<sub>H</sub> 5.09, 5.02, 4.98, 4.92&#xA0;ppm; &#x3B4;<sub>C</sub> 103.4, 102.9, 101.8; 99.6&#xA0;ppm), and C-4 of <italic>E</italic>- (&#x3B4;<sub>C</sub> 58.2, 58.0, 57.9, 56.7&#xA0;ppm) and <italic>Z</italic>-isomers (53.3, 53.1, 52.9, 52.1&#xA0;ppm) were observed, <italic>inter alia</italic>, in the <sup>1</sup>H and <sup>13</sup>C NMR spectra of tetrasaccharide <bold>1</bold>.</p>
      <p>Pentasaccharide <bold>6</bold>, in which the <sc>d</sc>-perosamine chain is terminated by a <sc>d</sc>-rhamnose unit, was prepared from tetrasaccharide acceptor <bold>19</bold> (<xref rid="sch4" ref-type="fig">Scheme 4</xref>). This pentasaccharide was thought to lose the ability to be recognized by antibodies specific to the terminal unsubstituted <sc>d</sc>-perosamine residue (<xref rid="B21" ref-type="bibr">Mandal et al., 2017a</xref>). Thioglycoside <bold>27</bold>, which was used as the glycosyl donor, was synthesized by the reaction of known 1,2-diacetate <bold>26</bold> (<xref rid="B35" ref-type="bibr">Zhang et al., 2015</xref>) with 5-(<italic>tert-</italic>butyl)-2-methylthiophenol in the presence of BF<sub>3</sub>&#xB7;Et<sub>2</sub>O. Following NIS&#x2013;TMSOTf-promoted glycosylation of <bold>19</bold> with <bold>27</bold> produced pentasaccharide <bold>28</bold> in excellent yield. After deacetylation of <bold>28</bold>, product <bold>29</bold> was subjected to deprotection with the use of the common reaction sequence (<xref rid="sch4" ref-type="fig">Scheme 4</xref>) resulting in the formation of target pentasaccharide <bold>6</bold>.</p>
      <fig position="float" id="sch4">
        <label>SCHEME 4</label>
        <caption>
          <p>Synthesis of pentasaccharide <bold>6</bold>.</p>
        </caption>
        <graphic xlink:href="FCHEM_fchem-2024-1424157_wc_sch4" position="float"/>
      </fig>
    </sec>
    <sec sec-type="conclusion" id="s3">
      <title>Conclusion</title>
      <p>In conclusion, an efficient approach to the synthesis of oligosaccharides related to the M epitope of the <italic>Brucella</italic> O-polysaccharide has been developed. The approach is based on the use of the (1&#x2192;3)-linked disaccharide thioglycoside as the key donor block. This disaccharide donor mimics the unique structural fragment of the M epitope with the (1&#x2192;3)-linkage between two N-formyl-<sc>d</sc>-perosamine residues. Its application allowed the straightforward assembly of a set of four protected oligosaccharides, which comprised the disaccharide, two trisaccharides, and the tetrasaccharide, in five glycosylation steps. Following deprotection included reduction of azido groups, N-formylation, O-debenzylation, and de-N-trifluoroacetylation and produced free oligosaccharides as 3-aminopropyl glycosides. Using the partially protected tetrasaccharide as the glycosyl acceptor, the pentasaccharide devoid of terminal <sc>d</sc>-perosamine through its capping with a <sc>d</sc>-rhamnose residue has been also prepared. The synthesized oligosaccharides will be used for development of a diagnostic assay to identify brucellosis in animals and humans as well as the potential ligands to design vaccine candidates.</p>
    </sec>
    <sec id="s4">
      <title>Experiment</title>
      <sec id="s4-1">
        <title>General</title>
        <p>NMR spectra were recorded on a Bruker Avance 600 NMR spectrometer. Protected oligosaccharides were measured in chloroform-d (CDCl<sub>3</sub>), and <sup>1</sup>H NMR chemical shifts were referenced to the solvent residual signal (&#x3B4;<sub>H</sub> 7.27). <sup>13</sup>C chemical shifts were referenced to the central resonance of CDCl<sub>3</sub> (&#x3B4;<sub>C</sub> 77.0). Free oligosaccharides were measured in deuterium oxide (D<sub>2</sub>O) with suppression of the HOD signal. Acetone (&#x3B4;<sub>H</sub> 2.225, &#x3B4;<sub>C</sub> 31.45) was used as an internal standard. Signal assignment was made using COSY, TOCSY, HSQC, and ROESY experiments. In the presentation of NMR data, monosaccharide residues in oligosaccharides are denoted by the capital letters (A, B, C, etc.) starting from the reducing end. NMR spectra of synthesized compounds are presented in the <xref rid="s10" ref-type="sec">Supplementary Material</xref>. High-resolution mass spectrometry (HRMS) with electrospray ionization (ESI) was performed on a MicrOTOF II (Bruker Daltonics) instrument. Optical rotations were measured using a JASCO P-2000 polarimeter at 20&#xB0;C&#x2013;25&#xB0;C in chloroform (protected oligosaccharides) or water (free oligosaccharides). TLC was performed on Silica Gel 60 F<sub>254</sub> plates (Merck) and visualization was accomplished using UV light or by charring at &#x223C;150&#xB0;C with orcinol&#x2013;phosphoric acid (180&#xA0;mg of orcinol in a mixture of 85% H<sub>3</sub>PO<sub>4</sub> (10&#xA0;mL), ethanol (5&#xA0;mL), and water (85&#xA0;mL)). Column chromatography was carried out using Silica Gel 60 (40&#x2013;63&#x3BC;m; Merck Millipore). Gel-permeation chromatography of free oligosaccharides was performed on a Toyopearl TSK HW-40(S) column (2.8 &#xD7; 80&#xA0;cm) in 0.1&#xA0;M acetic acid. A K-2401 refractive index detector (Knauer) was used to monitor gel-permeation chromatography. All moisture-sensitive reactions were carried out using dry solvents under dry argon. Powdered molecular sieve 4&#xA0;&#xC5; was activated at 300&#xB0;C under vacuum (&#x223C;1&#xA0;mbar) for 30&#xA0;min directly prior to the reaction. Solutions were concentrated under reduced pressure using a rotatory evaporator at 40&#xB0;C (bath temperature).</p>
        <p>
<bold>5-(<italic>tert</italic>-Butyl)-2-methylphenyl 4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-1-thio-&#x3B1;-</bold>
<sc>
<bold>d</bold>
</sc>
<bold>-mannopyranoside (9)</bold>. BF<sub>3</sub>&#xB7;Et<sub>2</sub>O (84&#xA0;&#x3BC;L, 0.67&#xA0;mmol) was added to a solution of 1,3-diacetate <bold>7</bold> (203&#xA0;mg, 0.56&#xA0;mmol) and 5-(<italic>tert</italic>-butyl)-2-methylthiophenol (153&#xA0;&#x3BC;L, 0.84&#xA0;mmol) in DCM (4&#xA0;mL) upon chilling in an ice bath. The mixture was stirred for 10&#xA0;min. with chilling and then at room temperature for 1.5&#xA0;h. The resulting mixture was diluted with chloroform (50&#xA0;mL), washed with water (30&#xA0;mL) and saturated aqueous NaHCO<sub>3</sub> (30&#xA0;mL). The solvent was evaporated and the residue was purified by column chromatography (petroleum ether&#x2013;EtOAc, 0&#x2192;5%) to give thioglycoside <bold>8</bold> (255&#xA0;mg, 94%) as a colorless syrup; &#x3B1;,&#x3B2; ratio &#x223C;6.3:1. <sup>1</sup>H NMR (600 MHz,CDCl<sub>3</sub>): &#x3B4; 7.62&#x2013;7.13 (m, 9.3 H, Ar), 5.44 (s, 1 H, H-1<sub>&#x3B1;</sub>), 5.15 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, <italic>J</italic>
<sub>3,4</sub> = 10.4 Hz, H-3<sub>&#x3B1;</sub>), 4.91 (d, 0.16 H, <italic>J</italic> = 11.8 Hz, PhC<italic>Ha</italic>Hb<sub>&#x3B2;</sub>) 4.84 (dd, 0.16 H, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, <italic>J</italic>
<sub>3,4</sub> = 10.2 Hz, H-3<sub>&#x3B2;</sub>), 4.78 (d, 0.16 H, <italic>J</italic> = 11.8 Hz, PhCHa<italic>Hb</italic>
<sub>&#x3B2;</sub>), 4.73 (s, 1 H, H-1<sub>&#x3B2;</sub>), 4.70 (d, 1 H, <italic>J</italic> = 12.2 Hz, PhC<italic>Ha</italic>Hb<sub>&#x3B1;</sub>), 4.52 (d, 1 H, <italic>J</italic> = 12.2 Hz, PhCHa<italic>Hb</italic>
<sub>&#x3B1;</sub>), 4.25 (d, 0.16 H, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, H-2<sub>&#x3B2;</sub>), 4.16&#x2013;4.11 (m, 2 H, H-2<sub>&#x3B1;</sub>, H-5<sub>&#x3B1;</sub>), 3.76&#x2013;3.71 (m, 1.16 H, H-4<sub>&#x3B1;</sub>, H-4<sub>&#x3B2;</sub>), 3.30 (dq, 0.16 H, <italic>J</italic>
<sub>5,6</sub> = 6.3 Hz, <italic>J</italic>
<sub>4,5</sub> = 9.8 Hz, H-5<sub>&#x3B2;</sub>), 2.38 (s, 0.5 H, Ar-C<italic>H</italic>
<sub>
<italic>3</italic>&#x3B2;</sub>), 2.36 (s, 3 H, Ar-C<italic>H</italic>
<sub>
<italic>3</italic>&#x3B1;</sub>), 2.10 (s, 3 H, CH<sub>3</sub>CO<sub>&#x3B1;</sub>), 2.05 (s, 0.5 H, CH<sub>3</sub>CO<sub>&#x3B2;</sub>), 1.46 (d, 0.5 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6<sub>&#x3B2;</sub>), 1.40 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sub>&#x3B1;</sub>), 1.32 (s, 10.4 H, Ar-C(C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>)<sub>&#x3B1;&#x3B2;</sub>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 169.9 (CH<sub>3</sub>
<italic>C</italic>O), 149.8, 137.2, 136.4, 132.7, 130.0, 129.8, 129.4, 129.0, 128.5, 128.1, 128.0, 124.8 (Ar), 87.1 (C-1<sub>&#x3B1;</sub>), 84.8 (C-1<sub>&#x3B2;</sub>), 77.6 (C-2<sub>&#x3B2;</sub>), 76.4 (C-2<sub>&#x3B1;</sub>), 76.0 (Ph<italic>C</italic>H<sub>2&#x3B2;</sub>), 75.9 (C-3<sub>&#x3B2;</sub>), 75.3 (C-5<sub>&#x3B2;</sub>), 72.7 (C-3<sub>&#x3B1;</sub>), 72.5 (Ph<italic>C</italic>H<sub>2&#x3B1;</sub>), 68.3 (C-5<sub>&#x3B1;</sub>), 62.9 (C-4<sub>&#x3B1;</sub>), 62.3 (C-4<sub>&#x3B2;</sub>), 31.2 (C(<italic>C</italic>H<sub>3</sub>)<sub>3</sub>), 20.9 (<italic>C</italic>H<sub>3</sub>CO), 20.2 (<italic>C</italic>H<sub>3</sub>-Ar), 18.7 (C-6<sub>&#x3B2;</sub>), 18.4 (C-6<sub>&#x3B1;</sub>).</p>
        <p>1&#xA0;M Sodium methoxide in MeOH (50&#xA0;&#x3BC;L) was added to a solution of 3-acetate <bold>8</bold> (255&#xA0;mg, 0.53&#xA0;mmol) in MeOH (5&#xA0;mL), and the mixture was stirred for 2&#xA0;h at room temperature. The mixture was neutralized with Amberlite IR-120 (H<sup>+</sup>), the resin was filtered off and washed with MeOH (4 &#xD7; 4&#xA0;mL), and the filtrate was concentrated. The residue was subjected to column chromatography (petroleum ether&#x2013;EtOAc, 2&#x2192;8%) to produce &#x3B1;-anomer <bold>9</bold> (192&#xA0;mg, 82%) and &#x3B2;-anomer (29&#xA0;mg, 12%).</p>
        <p>&#x3B1;-Anomer <bold>9</bold>, colorless syrup, [&#x3B1;]<sub>D</sub> +95 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): &#x3B4; 7.56&#x2013;7.16 (m, 8 H, Ar), 5.53 (s, 1 H, H-1), 4.77 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhC<italic>Ha</italic>Hb), 4.55 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhCHa<italic>Hb</italic>), 4.07 (dq, 1 H, <italic>J</italic>
<sub>4,5</sub> = 9.9 Hz, <italic>J</italic>
<sub>5,6</sub> = 6.3 Hz, H-5), 4.02 (d, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.7 Hz, H-2), 3.94 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.7 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.8 Hz, H-3), 3.40 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4), 2.37 (s, 3 H, Ar-C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>), 1.37 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6), 1.33 (s, 9 H, Ar-C(C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>)). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 149.8, 136.9, 136.4, 132.6, 130.0, 129.6, 128.7, 128.3, 128.1, 125.0 (Ar), 84.3 (C-1), 78.9 (C-2), 72.3 (Ph<italic>C</italic>H<sub>2</sub>), 70.9 (C-3), 67.9 (C-5), 66.8 (C-4), 31.3 (C(<italic>C</italic>H<sub>3</sub>)<sub>3</sub>), 20.1 (<italic>C</italic>H<sub>3</sub>-Ar), 18.3 (C-6). HRMS (ESI): calcd. for C<sub>24</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub>S [M + Na]+ <italic>m/z</italic> 464.1978; found <italic>m/z</italic> 464.1968.</p>
        <p>&#x3B2;-Anomer, colorless syrup, [&#x3B1;]<sub>D</sub> &#x2013;96 (c 0.5, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): &#x3B4; 7.63&#x2013;7.14 (m, 8 H, Ar), 5.16 (d, 1 H, <italic>J</italic> = 11.5 Hz, PhC<italic>Ha</italic>Hb), 4.80 (d, 1 H, <italic>J</italic> = 11.5 Hz, PhCHa<italic>Hb</italic>), 4.72 (s, 1 H, H-1), 4.10 (d, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.5 Hz, H-2), 3.61 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.6 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.7 Hz, H-3), 3.35 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4), 3.23 (dq, 1 H, <italic>J</italic>
<sub>4,5</sub> = 9.8 Hz, <italic>J</italic>
<sub>5,6</sub> = 6.3 Hz, H-5), 2.40 (s, 3 H, Ar-C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>), 1.44 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6), 1.33 (s, 9 H, Ar-C(C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>)). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 149.6, 137.5, 135.7, 133.6, 129.8, 128.7, 128.5, 128.3, 128.1, 124.6 (Ar), 87.1 (C-1), 80.1 (C-2), 76.5 (Ph<italic>C</italic>H<sub>2</sub>), 75.2 (C-5), 74.3 (C-3), 66.2 (C-4), 31.3 (C(<italic>C</italic>H<sub>3</sub>)<sub>3</sub>), 20.2 (<italic>C</italic>H<sub>3</sub>-Ar), 18.7 (C-6). HRMS (ESI): calcd. for C<sub>24</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub>S [M + Na]<sup>+</sup>
<italic>m/z</italic> 464.1978; found <italic>m/z</italic> 464.1981.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 2-<italic>O</italic>-acetyl-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-</bold>
<sc>
<bold>d</bold>
</sc>
<bold>-mannopyranoside (12).</bold> TMSOTf (0.59&#xA0;mL, 3.24&#xA0;mmol) was added to a chilled (ice bath) solution of 1,2-diacetate <bold>10</bold> (906&#xA0;mg, 2.49&#xA0;mmol) and alcohol <bold>11</bold> (554&#xA0;mg, 3.24&#xA0;mmol) in DCM (15&#xA0;mL). The mixture was stirred for 20&#xA0;min. upon chilling and then 2.5&#xA0;h at room temperature. After dilution with DCM (100&#xA0;mL), the mixture was washed with saturated aqueous NaHCO<sub>3</sub> (50&#xA0;mL) and water (2 &#xD7; 50&#xA0;mL), and concentrated. The residue was purified by column chromatography (petroleum ether&#x2013;EtOAc, 15&#x2192;30%) to yield glycoside <bold>12</bold> (1.02&#xA0;g, 86%) as a colorless syrup, , [&#x3B1;]<sub>D</sub> +88 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600&#xA0;MHz, CDCl<sub>3</sub>): &#x3B4; 7.39&#x2013;7.29 (m, 5 H, Ar), 6.77 (br. s, 1 H, CF<sub>3</sub>CONH), 5.32 (br. s, 1 H, H-2), 4.76 (s, 1 H, H-1), 4.68 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhC<italic>Ha</italic>Hb), 4.54 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhCHa<italic>Hb</italic>), 3.82&#x2013;3.78 (m, 1 H, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.77 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.3 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.8 Hz, H-3), 3.54&#x2013;3.45 (m, 4 H, OCHa<italic>Hb</italic>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N, H-5), 3.44 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4), 2.14 (s, 3 H, CH<sub>3</sub>CO), 1.96&#x2013;1.84 (m, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.34 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 170.2 (CH<sub>3</sub>
<italic>C</italic>O), 137.1, 128.4, 128.2, 128.0 (Ar), 97.9 (C-1), 76.2 (C-3), 71.7 (Ph<italic>C</italic>H<sub>2</sub>), 67.3 (C-2), 76.2 (C-5), 66.1 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 63.8 (C-4), 38.1 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.3 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 20.9 (<italic>C</italic>H<sub>3</sub>CO), 18.4 (C-6). HRMS (ESI): calcd. for C<sub>20</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>6</sub> [M + Na]<sup>+</sup>
<italic>m/z</italic> 497.1618; found <italic>m/z</italic> 497.1609.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-</bold>
<sc>
<bold>d</bold>
</sc>
<bold>-mannopyranoside (13).</bold> 1 M Sodium methoxide in MeOH (100&#xA0;&#x3BC;L) was added to a solution of 2-acetate <bold>12</bold> (1.02&#xA0;g, 2.15&#xA0;mmol) in MeOH (15&#xA0;mL) and the mixture was stirred for 5&#xA0;h at room temperature. Amberlite IR-120 (H<sup>+</sup>) was added until neutrality, the resin was filtered off and washed with MeOH (5 &#xD7; 4&#xA0;mL), and the filtrate was concentrated. Column chromatography of the residue (toluene&#x2013;EtOAc, 15&#x2192;30%) provided compound <bold>13</bold> (700&#xA0;mg, 75%) as a colorless syrup, [&#x3B1;]<sub>D</sub> +104 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600&#xA0;MHz, CDCl<sub>3</sub>): &#x3B4; 7.43&#x2013;7.33 (m, 5 H, Ar), 6.82 (br. s, 1 H, CF<sub>3</sub>CONH), 4.83 (s, 1 H, H-1), 4.71 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhC<italic>Ha</italic>Hb), 4.67 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhCHa<italic>Hb</italic>), 3.99 (br. s, 1 H, H-2), 3.85&#x2013;3.80 (m, 1 H, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.68 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.3 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.3 Hz, H-3), 3.56&#x2013;3.42 (m, 5 H, OCHa<italic>Hb</italic>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N, H-4, H-5), 2.58 (br. s, 1 H, OH), 1.94&#x2013;1.83 (m, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.34 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 5.9 Hz, H-6). <sup>13</sup>C NMR (150 Hz, CDCl<sub>3</sub>): &#x3B4; 137.1, 128.6, 128.2, 128.0 (Ar), 99.2 (C-1), 78.5 (C-3), 72.1 (Ph<italic>C</italic>H<sub>2</sub>), 67.1 (C-2), 67.0 (C-5), 66.3 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 63.8 (C-4), 38.4 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.2 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 18.4 (C-6). HRMS (ESI): calcd. for C<sub>18</sub>H<sub>23</sub>F<sub>3</sub>N<sub>4</sub>O<sub>5</sub> [M + Na]<sup>+</sup>
<italic>m/z</italic> 455.1513; found <italic>m/z</italic> 455.1506.</p>
        <p>
<bold>4-(<italic>tert</italic>-Butyl)-2-methylphenyl 2-<italic>O</italic>-acetyl-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-1-thio-&#x3B1;-<sc>d</sc>-mannopyranoside (15)</bold>. A mixture of acceptor <bold>9</bold> (168&#xA0;mg, 0.381&#xA0;mmol), donor <bold>14</bold> (204&#xA0;mg, 0.438&#xA0;mmol) and mol. sieve 4&#xA0;&#xC5; (400&#xA0;mg) in DCM (6&#xA0;mL) was stirred for 1.5&#xA0;h at room temperature and cooled to &#x2212;55&#xB0;C. TMSOTf (16&#xA0;&#x3BC;L, 0.088&#xA0;mmol) was added and the mixture was stirred for 30&#xA0;min. at &#x2212;55 &#xF7; &#x2212;50&#xB0;C. Then, over the next 30&#xA0;min., the temperature was gradually increased to &#x2212;25&#xB0;C and the mixture was stirred at this temperature for another 30&#xA0;min. The reaction was quenched by adding Et<sub>3</sub>N (50&#xA0;&#x3BC;L), the mixture was diluted with chloroform (50&#xA0;mL), the solids were filtered off through a Celite layer and washed with chloroform. The filtrate was washed with water (50&#xA0;mL), and the solvent was evaporated. The residue was subjected to gel-permeation chromatography on a Bio-Beads S-X3 column (3.5 &#xD7; 70&#xA0;cm) in toluene; fractions containing disaccharide <bold>15</bold> were pooled and concentrated. The product obtained was additionally purified by silica gel column chromatography (petroleum ether&#x2013;EtOAc, 5&#x2192;8%) to produce disaccharide <bold>15</bold> (251&#xA0;mg, 88%) as a colorless syrup, [&#x3B1;]<sub>D</sub> +129 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): &#x3B4; 7.52&#x2013;7.14 (m, 13 H, Ar), 5.53 (br. s, 1 H, H-2<sup>B</sup>), 5.48 (s, 1 H, H-1<sup>A</sup>), 5.12 (s, 1 H, H-1<sup>B</sup>), 4.72 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhC<italic>Ha</italic>Hb), 4.68 (d, 1 H, <italic>J</italic> = 12.0 Hz, PhC<italic>Ha</italic>Hb<bold>&#x2032;</bold>), 4.54 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhCHa<italic>Hb</italic>), 4.53 (d, 1 H, <italic>J</italic> = 12.0 Hz, PhCHa<italic>Hb</italic>&#x2032;), 4.04 (dq, 1 H, <italic>J</italic>
<sub>4,5</sub> = 9.8 Hz, <italic>J</italic>
<sub>5,6</sub> = 6.1 Hz, H-5<sup>A</sup>), 4.01 (br. s, 1 H, H-2<sup>A</sup>), 3,96 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.0 Hz, <italic>J</italic>
<sub>3,4</sub> = 10.0 Hz, H-3<sup>A</sup>), 3.88 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.8 Hz, H-3<sup>B</sup>), 3.72 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4<sup>A</sup>), 3.67 (dq, 1 H, <italic>J</italic>
<sub>4,5</sub> = 10.2 Hz, <italic>J</italic>
<sub>5,6</sub> = 6.3 Hz, H-5<sup>B</sup>), 3.46 (t, 1 H, <italic>J</italic> = 10.0 Hz, H-4<sup>B</sup>), 2.36 (s, 3 H, Ar-C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>), 2.17 (s, 3 H, CH<sub>3</sub>CO), 1.39 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>A</sup>), 1.32 (s, 9 H, Ar-C(C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>)), 1.28 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6<sup>B</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 170.0 (CH<sub>3</sub>
<italic>C</italic>O), 149.9, 137.2, 136.4, 132.6, 130.0, 129.4, 128.6, 128.4, 128.3, 128.0, 127.9, 127.5, 125.0 (Ar), 99.8 (C-1<sup>B</sup>), 84.3 (C-1<sup>A</sup>), 79.6 (C-3<sup>A</sup>), 78.5 (C-2<sup>A</sup>), 75.8 (C-3<sup>B</sup>), 71.7, 71.5 (2 Ph<italic>C</italic>H<sub>2</sub>), 68.5 (C-5<sup>A</sup>), 67.9 (C-5<sup>B</sup>), 67.3 (C-2<sup>B</sup>), 64.4 (C-4<sup>A</sup>), 63.8 (C-4<sup>B</sup>), 31.3 (C(<italic>C</italic>H<sub>3</sub>)<sub>3</sub>), 20.9 (CH<sub>3</sub>CO), 20.2 (<italic>C</italic>H<sub>3</sub>-Ar), 18.6 (C-6<sup>B</sup>), 18.4 (C-6<sup>A</sup>). HRMS (ESI): calcd. for C<sub>39</sub>H<sub>48</sub>N<sub>6</sub>O<sub>7</sub>S [M + NH<sub>4</sub>]<sup>+</sup>
<italic>m/z</italic> 762.3643; found <italic>m/z</italic> 762.3636.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 2-<italic>O</italic>-acetyl-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranoside (16).</bold> A mixture of donor <bold>15</bold> (251&#xA0;mg, 0.337&#xA0;mmol), acceptor <bold>13</bold> (132&#xA0;mg, 0.306&#xA0;mmol) and mol. sieve 4&#xA0;&#xC5; (500&#xA0;mg) in DCM (6&#xA0;mL) was stirred for 1&#xA0;h at room temperature, and then was cooled to &#x2212;45&#xB0;C. NIS (152&#xA0;mg, 0.674&#xA0;mmol) and TMSOTf (12&#xA0;&#x3BC;L) were added and the mixture was stirred for 1&#xA0;h, gradually increasing the temperature to &#x2212;10&#xB0;C. The reaction was quenched by adding pyridine (50&#xA0;&#x3BC;L), the mixture was diluted with chloroform (10&#xA0;mL), the mol. sieve was filtered off and washed with chloroform (4 &#xD7; 5&#xA0;mL). The filtrate was washed with 0.5&#xA0;M Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (30&#xA0;mL) and water (50&#xA0;mL), and concentrated. Two consecutive column chromatographies (first in toluene&#x2013;EtOAc (10&#x2192;15%) and then in petroleum ether&#x2013;EtOAc (15&#x2192;25%)) resulted in trisaccharide <bold>16</bold> (273&#xA0;mg, 90%) as a colorless foam, [&#x3B1;]<sub>D</sub> +75 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600&#xA0;MHz, CDCl<sub>3</sub>): &#x3B4; 7.39&#x2013;7.12 (m, 15 H, Ar), 6.68 (poorly resolved t, 1 H, NHCOCF<sub>3</sub>), 5.49 (br. s, H-2<sup>C</sup>), 5.08 (s, 1 H, H-1<sup>B</sup>), 5.06 (br. s, 1 H, H-1<sup>C</sup>), 4.72&#x2013;4.68 (m, 3 H, H-1<sup>A</sup>, PhC<italic>Ha</italic>Hb, PhC<italic>Ha</italic>Hb&#x2032;), 4.57 (d, 1 H, <italic>J</italic> = 10.8 Hz, PhCHa<italic>Hb</italic>), 4.50 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhCHa<italic>Hb</italic>&#x2032;), 4.24 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhC<italic>Ha</italic>Hb&#x2032;&#x2032;), 4.15 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhCHa<italic>Hb</italic>&#x2032;&#x2032;), 3.99 (br. s, 1 H, H-2<sup>A</sup>), 3.90 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.0 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.8 Hz, H-3<sup>B</sup>), 3.82&#x2013;3.78 (m, 2 H, H-3<sup>C</sup>, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.72&#x2013;3.68 (m, 2 H, C-2<sup>B</sup>, C-3<sup>A</sup>), 3.61 (t, 1 H, <italic>J</italic> = 10.0 Hz, H-4<sup>B</sup>), 3.58&#x2013;3.43 (m, 6 H, H-5<sup>A</sup>, H-5<sup>B</sup>, H-5<sup>C</sup>, OCHa<italic>Hb</italic>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 3,41 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4<sup>C</sup>), 3.38 (t, 1 H, <italic>J</italic> = 10.0, H-4<sup>A</sup>), 2.14 (s, 3 H, CH<sub>3</sub>CO), 1.93&#x2013;1.85 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.35 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.2 Hz, H-6<sup>B</sup>), 1.34 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6<sup>A</sup>), 1.29 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>C</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 170.0 (CH<sub>3</sub>
<italic>C</italic>O), 137.3, 137.2, 137.1, 128.5, 128.4, 128.3, 128.2, 128.0, 127.9, 127.8, 127.4, 99.6 (C-1<sup>C</sup>), 99.1 (C-1<sup>A</sup>), 98.2 (C-1<sup>B</sup>), 78.4 (C-3<sup>A</sup>), 78.3 (C-3<sup>B</sup>), 76.2 (C-2<sup>B</sup>), 75.8 (C-3<sup>C</sup>), 72.9 (C-2<sup>A</sup>), 72.5, 71.7, 71.5 (3 Ph<italic>C</italic>H<sub>2</sub>), 68.0 (C-5<sup>B</sup>), 67.7 (C-5<sup>C</sup>), 67.5 (C-5<sup>A</sup>), 67.3 (C-2<sup>C</sup>), 65.9 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 64.4 (C-4<sup>A</sup>), 64.1 (C-4<sup>B</sup>), 63.7 (C-4<sup>C</sup>), 38.1 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.3 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 20.9 (<italic>C</italic>H<sub>3</sub>CO), 18.6, 18.5 (&#xD7;2) (C-6<sup>A</sup>, C-6<sup>B</sup>, C-6<sup>C</sup>). HRMS (ESI): calcd. for C<sub>46</sub>H<sub>55</sub>F<sub>3</sub>N<sub>10</sub>O<sub>12</sub> [M + NH<sub>4</sub>]<sup>+</sup>
<italic>m/z</italic> 1014.4291; found <italic>m/z</italic> 1014.4291.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranoside (17)</bold>. 1 M sodium methoxide in MeOH (60&#xA0;&#x3BC;L) was added to a solution of monoacetate <bold>16</bold> (273&#xA0;mg, 0.337&#xA0;mmol) in MeOH (6&#xA0;mL), and the mixture was stirred for 4&#xA0;h at room temperature. The solution was made neutral by adding Amberlite IR-120 (H<sup>+</sup>), the resin was filtered off and washed with MeOH (4 &#xD7; 4&#xA0;mL). The filtrate was concentrated, and the residue was purified by column chromatography (toluene&#x2013;EtOAc, 15&#x2192;25%) to produce deacetylated trisaccharide <bold>17</bold> (250&#xA0;mg, 96%) as a colorless foam, [&#x3B1;]<sub>D</sub> +57 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600&#xA0;MHz, CDCl<sub>3</sub>): &#x3B4; 7.42&#x2013;7.13 (m, 15 H, Ar), 6.70 (poorly resolved t, 1 H, NHCOCF<sub>3</sub>), 5.11 (s, 1 H, H-1<sup>C</sup>), 5.10 (s, 1 H, H-1<sup>B</sup>), 4.74&#x2013;4.65 (m, 4 H, H-1<sup>A</sup>, PhC<italic>H</italic>
<sub>
<italic>2</italic>
</sub>, PhC<italic>Ha</italic>Hb&#x2032;), 4.58 (d, 1 H, <italic>J</italic> = 10.8 Hz, PhCHa<italic>Hb</italic>&#x2032;), 4.23 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhC<italic>Ha</italic>Hb&#x2032;&#x2032;), 4.17 (br. s, 1 H, H-2<sup>C</sup>), 4.13 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhCHa<italic>Hb</italic>&#x2032;&#x2032;), 4.00 (br. s, 1 H, H-2<sup>A</sup>), 3.92 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 2.8 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.6 Hz, H-3<sup>B</sup>), 3.82&#x2013;3.78 (m, 1 H, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.72-3.69 (m, 3 H, H-2<sup>B</sup>, H-3<sup>A</sup>, H-3<sup>C</sup>), 3.60 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4<sup>B</sup>), 3.58&#x2013;3.44 (m, 6 H, H-5<sup>A</sup>, H-5<sup>B</sup>, H-5<sup>C</sup>, OCHa<italic>Hb</italic>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 3.43 (t, 1 H, <italic>J</italic> = 10.0 Hz, H-4<sup>C</sup>), 3.39 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4<sup>A</sup>), 2.50 (s, 1 H, OH), 1.94-1.85 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.36&#x2013;1.33 (m, 6 H, H-6<sup>A</sup>, H-6<sup>B</sup>), 1.20 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>C</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 137.4, 137.2, 128.6, 128.5, 128.3, 128.2, 128.1, 128.0, 127.8, 127.4 (Ar), 101.2 (C-1<sup>C</sup>), 99.1 (C-1<sup>A</sup>), 98.2 (C-1<sup>B</sup>), 78.5, 78.1 (&#xD7;2) (C-3<sup>A</sup>, C-3<sup>B</sup>, C-3<sup>C</sup>), 76.4 (C-2<sup>A</sup>), 72.6, 71.9, 71.7 (3 Ph<italic>C</italic>H<sub>2</sub>), 68.0 (C-5<sup>B</sup>), 67.5 (C-5<sup>A</sup>), 67.4 (C-5<sup>C</sup>), 67.2 (C-2<sup>C</sup>), 65.9 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 64.5 (C-4<sup>A</sup>), 64.2 (C-4<sup>B</sup>), 63.6 (C-4<sup>C</sup>), 38.1 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.3 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 18.6, 18.5 (C-6<sup>A</sup>, C-6<sup>B</sup>), 18.4 (C-6<sup>C</sup>). HRMS (ESI): calcd. for C<sub>44</sub>H<sub>53</sub>F<sub>3</sub>N<sub>10</sub>O<sub>11</sub> [M + NH<sub>4</sub>]<sup>+</sup>
<italic>m/z</italic> 972.4186; found <italic>m/z</italic> 972.4195.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 2-<italic>O</italic>-acetyl-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranoside (18)</bold>. A mixture of imidate <bold>14</bold> (53&#xA0;mg, 0.113&#xA0;mmol), acceptor <bold>17</bold> (90&#xA0;mg, 0.094&#xA0;mmol) and mol. sieve 4&#xA0;&#xC5; (200&#xA0;mg) in DCM (2&#xA0;mL) was stirred for 1 h at room temperature and cooled to &#x2212;40&#xB0;C. TMSOTf (4.2&#xA0;&#x3BC;L, 23&#xA0;&#x3BC;mol) was added, and the mixture was stirred for 1.5&#xA0;h, while the temperature was gradually increased to &#x2212;10&#xB0;C. After adding Et<sub>3</sub>N (20&#xA0;&#x3BC;L), the mixture was diluted with chloroform (10&#xA0;mL), the solids were filtered off and washed with chloroform (4 &#xD7; 4&#xA0;mL). The filtrate was washed with 1 M HCl (10&#xA0;mL), water (30&#xA0;mL), and the solvent was evaporated. The residue was purified by column chromatography (petroleum ether&#x2013;EtOAc, 20&#x2192;25%) to give tetrasaccharide <bold>18</bold> (116&#xA0;mg, 98%) as a colorless foam, [&#x3B1;]<sub>D</sub> +59 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600&#xA0;MHz, CDCl<sub>3</sub>): &#x3B4; 7.40&#x2013;7.25 (m, 20 H, Ar), 6.64 (poorly resolved t, 1 H, NHCOCF<sub>3</sub>), 5.43 (br. s, 1 H, H-2<sup>D</sup>), 5.09 (s, 1 H, H-1<sup>B</sup>), 5.00 (s, 1 H, H-1<sup>C</sup>), 4.90 (s, 1 H, H-1<sup>D</sup>), 4.75-4.69 (m, 3 H, H-1<sup>A</sup>, PhC<italic>Ha</italic>Hb, PhC<italic>Ha</italic>Hb&#x2032;), 4.65 (d, 1 H, <italic>J</italic> = 11.6 Hz, PhC<italic>Ha</italic>Hb&#x2032;&#x2032;), 4.62 (d, 1 H, <italic>J</italic> = 11.6 Hz, PhCHa<italic>Hb</italic>&#x2032;&#x2032;), 4.57 (d, 1 H, <italic>J</italic> = 11.2 Hz, PhCHa<italic>Hb</italic>), 4.55 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhCHa<italic>Hb</italic>&#x2032;), 4.25 (d, 1 H, <italic>J</italic> = 12.0 Hz, PhC<italic>Ha</italic>Hb&#x2032;&#x2032;&#x2032;), 4.15(d, 1 H, <italic>J</italic> = 12.0 Hz, PhCHa<italic>Hb</italic>&#x2032;&#x2032;&#x2032;), 4.05 (br. s, 1 H, H-2<sup>C</sup>), 4.00 (br. s, 1 H, H-2<sup>A</sup>), 3.85 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.0 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.4 Hz, H-3<sup>B</sup>), 3.82&#x2013;3.78 (m, 2 H, H-3<sup>D</sup>, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.71 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.0 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.6 Hz, H-3<sup>A</sup>), 3.69 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.0 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.6 Hz, H-3<sup>C</sup>), 3.64&#x2013;3.59 (m, 2 H, H-2<sup>B</sup>, H-5<sup>D</sup>), 3.59&#x2013;3.52 (m, 2 H, H-4<sup>B</sup>), H-5<sup>B</sup>), 3.50-3.38 (m, 6 H, H-4<sup>D</sup>, H-5<sup>A</sup>, H-5<sup>C</sup>, OCHa<italic>Hb</italic>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 3.36 (t, 1 H, <italic>J</italic> = 10.0 Hz, H-4<sup>A</sup>), 3.35 (t, 1 H, <italic>J</italic> = 10.0 Hz, H-4<sup>C</sup>), 2.09 (s, 3 H, CH<sub>3</sub>CO), 1.93-1.85 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.35&#x2013;1.32 (m, 9 H, H-6<sup>A</sup>, H-6<sup>B</sup>, H-6<sup>D</sup>), 1.18 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>C</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 169.7 (CH<sub>3</sub>
<italic>C</italic>O), 137.4, 137.3, 137.1, 128.6, 128.5, 128.4, 128.2, 128.0, 127.8, 127.5 (Ar), 100.7 (C-1<sup>C</sup>), 99.4 (C-1<sup>D</sup>), 99.1 (C-1<sup>A</sup>), 98.3 (C-1<sup>B</sup>), 78.4 (C-3<sup>A</sup>), 77.5 (C-3<sup>C</sup>), 77.3 (C-3<sup>B</sup>), 76.3 (C-2<sup>B</sup>), 75.5 (C-3<sup>D</sup>), 73.3 (C-2<sup>C</sup>), 72.8 (C-2<sup>A</sup>), 72.5, 71.9, 71.8, 71.6 (4 Ph<italic>C</italic>H<sub>2</sub>), 68.0, (C-5<sup>B</sup>), 67.8 (C-5<sup>C</sup>), 67.7 (C-5<sup>D</sup>), 67.5 (C-5<sup>A</sup>), 67.1 (C-2<sup>D</sup>), 65.9 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 64.5 (C-4<sup>B</sup>), 64.4 (C-4<sup>A</sup>), 63.8 (C-4<sup>D</sup>), 63.7 (C-4<sup>C</sup>), 38.1 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.4 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 20.9 (<italic>C</italic>H<sub>3</sub>CO), 18.5 (&#xD7;2), 18.4 (&#xD7;2) (C-6<sup>A</sup>, C-6<sup>B</sup>, C-6<sup>C</sup>, C-6<sup>D</sup>). HRMS (ESI): calcd. for C<sub>59</sub>H<sub>70</sub>F<sub>3</sub>N<sub>13</sub>O<sub>15</sub> [M + NH<sub>4</sub>]<sup>+</sup>
<italic>m/z</italic> 1275.5405; found <italic>m/z</italic> 1275.5399.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranoside (19)</bold>. 1 M sodium methoxide (50&#xA0;&#x3BC;L) was added to a solution of compound <bold>18</bold> (298&#xA0;mg, 0.237&#xA0;mmol) in MeOH (5&#xA0;mL), and the mixture was stirred for 4.5&#xA0;h at room temperature. The solution was made neutral by adding Amberlite IR-120 (H<sup>+</sup>), the resin was filtered off and washed with MeOH (4 &#xD7; 4&#xA0;mL). The filtrate was evaporated, and the residue was subjected to column chromatography (toluene&#x2013;EtOAc, 10&#x2192;25%) to produce deacetylated tetrasaccharide <bold>19</bold> (274&#xA0;mg, 95%) as a colorless foam, [&#x3B1;]<sub>D</sub> +73 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): &#x3B4; 7.43&#x2013;7.26 (m, 20 H, Ar), 6.65 (br. s, 1 H, NHCOCF<sub>3</sub>), 5.09 (s, 1 H, H-1<sup>B</sup>), 5.03 (s, 1 H, H-1<sup>C</sup>), 5.00 (s, 1 H, H-1<sup>D</sup>), 4.74 (d, 1 H, <italic>J</italic> = 11.2 Hz, PhC<italic>Ha</italic>Hb), 4.72 (s, 1 H, H-1<sup>A</sup>), 4.71 (d, 1 H, <italic>J</italic> = 10.8 Hz, PhC<italic>Ha</italic>Hb&#x2032;), 4.69 (d, 1 H, <italic>J</italic> = 11.2 Hz, PhCHa<italic>Hb</italic>), 4.63 (s, 2 H, PhC<italic>H</italic>
<sub>
<italic>2</italic>
</sub>&#x2033;), 4.68 (d, 1 H, <italic>J</italic> = 10.8 Hz, PhCHa<italic>Hb</italic>&#x2032;), 4.25 (d, 1 H, <italic>J</italic> = 12.0 Hz, PhC<italic>Ha</italic>Hb&#x2034;), 4.16 (d, 1 H, <italic>J</italic> = 12.0 Hz, PhCHa<italic>Hb</italic>&#x2034;), 4.09 (br. s, 1 H, H-2<sup>C</sup>), 4.00 (br. s, 2 H, H-2<sup>A</sup>, H-2<sup>D</sup>), 3.86 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.0 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.5 Hz, H-3<sup>B</sup>), 3.83&#x2013;3.78 (m, 1 H, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.75&#x2013;3.69 (m, 3 H, H-3<sup>A</sup>, H-3<sup>C</sup>, H-3<sup>D</sup>), 3.66&#x2013;3.60 (m, 2 H, H-2<sup>B</sup>, H-5<sup>D</sup>), 3.60&#x2013;3.52 (m, 3 H, H-4<sup>B</sup>, H-5<sup>B</sup>, OCHa<italic>Hb</italic>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 3.51-3.39 (m, 5 H, H-4<sup>D</sup>, H-5<sup>A</sup>, H-5<sup>&#x421;</sup>, OCH<sub>2</sub>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 3.37 (t, 1 H, <italic>J</italic> = 10.0 Hz, H-4<sup>A</sup>), 3.32 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4<sup>C</sup>), 2.32 (br. s, 1 H, OH), 1.94-1.86 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.36&#x2013;1.33 (m, 9 H, H-6<sup>A</sup>, H-6<sup>B</sup>, H-6<sup>D</sup>), 1.19 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>C</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 137.4, 137.1, 128.6, 128.5, 128.4, 128.3, 128.2, 128.0, 127.8, 127.5 (Ar), 100.8 (C-1<sup>C</sup>), 100.7 (C-1<sup>D</sup>), 99.1 (C-1<sup>A</sup>), 98.4 (C-1<sup>B</sup>), 78.4 (C-3<sup>A</sup>), 77.7, 77.6 (C-3<sup>C</sup>, C-3<sup>D</sup>), 77.4 (C-3<sup>B</sup>), 76.3 (C-2<sup>B</sup>), 73.3 (C-2<sup>C</sup>), 72.8 (C-2<sup>A</sup>), 72.5, 72.1, 72.0, 71.8 (Ph<italic>C</italic>H<sub>2</sub>), 68.1 (C-5<sup>B</sup>), 67.9 (C-5<sup>C</sup>), 67.5 (C-5<sup>A</sup>), 67.4 (C-5<sup>D</sup>), 67.1 (C-2<sup>D</sup>), 65.9 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 64.5 (&#xD7;2) (C-4<sup>A</sup>, C-4<sup>B</sup>), 63.9 (C-4<sup>&#x421;</sup>), 63.8 (C-4<sup>D</sup>), 38.1 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.4 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 18.5 (&#xD7;3), 18.4 (C-6<sup>A</sup>, C-6<sup>B</sup>, C-6<sup>C</sup>, C-6<sup>D</sup>). HRMS (ESI): calcd. for C<sub>57</sub>H<sub>68</sub>F<sub>3</sub>N<sub>13</sub>O<sub>14</sub> [M + Na]<sup>+</sup>
<italic>m/z</italic> 1238.4853; found <italic>m/z</italic> 1238.4854.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 3-<italic>O</italic>-acetyl-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranoside (20)</bold>. A mixture of thiglycoside <bold>15</bold> (220&#xA0;mg, 0.295&#xA0;mmol), alcohol <bold>11</bold> (76&#xA0;mg, 0.444&#xA0;mmol) and mol. sieve 4&#xA0;&#xC5; in DCM (5&#xA0;mL) was stirred for 1&#xA0;h at room temperature and then cooled to &#x2212;45&#xB0;C. NIS (132&#xA0;mg, 0.587&#xA0;mmol) and TMSOTf (22&#xA0;&#x3BC;L, 0.121&#xA0;mmol) were added, and the mixture was stirred for 1 h with gradual increase of the temperature to &#x2212;10&#xB0;C. Pyridine (50&#xA0;&#x3BC;L) was added, the mixture was diluted with chloroform (10&#xA0;mL), the solids were filtered off and washed with chloroform (4 &#xD7; 4&#xA0;mL). The filtrate was washed with 0.5&#xA0;M Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (30&#xA0;mL) and water (50&#xA0;mL), and concentrated. Column chromatography of the residue (petroleum ether&#x2013;EtOAc, 20&#x2192;30%) produced glycoside <bold>20</bold> (194&#xA0;mg, 89%) as a colorless syrup, [&#x3B1;]<sub>D</sub> +83 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): &#x3B4; 7.39&#x2013;7.27 (m, 10 H, Ar), 6.57 (br. s, 1 H, NHCOCF<sub>3</sub>), 5.48 (br, s, 1 H, H-2<sup>B</sup>), 5.04 (s, 1 H, H-1<sup>B</sup>), 4.78 (s, 1 H, H-1<sup>A</sup>), 4.70 (d, 1 H, <italic>J</italic> = 11.2 Hz, PhC<italic>Ha</italic>Hb), 4.65 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhC<italic>Ha</italic>Hb&#x2032;), 4.60 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhCHa<italic>Hb</italic>&#x2032;), 4.53 (d, 1 H, <italic>J</italic> = 11.2 Hz, PhCHa<italic>Hb</italic>), 3.86 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.8 Hz, H-3<sup>B</sup>), 3.83 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, <italic>J</italic>
<sub>3,4</sub> = 10.2 Hz, H-3<sup>A</sup>), 3.78-3.74 (m, 1 H, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.71 (br. s, 1 H, H-2<sup>A</sup>), 3.69 (dq, 1 H, <italic>J</italic>
<sub>4,5</sub> = 10.0 Hz, <italic>J</italic>
<sub>5,6</sub> = 6.1 Hz, H-5<sup>B</sup>), 3.62 (t, 1 H, <italic>J</italic> = 10.0 Hz, H-4<sup>A</sup>), 3.53&#x2013;3.38 (m, 5 H, H-4<sup>B</sup>, H-5<sup>A</sup>, OCHa<italic>Hb</italic>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 2.14 (s, 3 H, CH<sub>3</sub>CO), 1.88&#x2013;1.83 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.35 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>A</sup>), 1.27 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>B</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 170.1 (CH<sub>3</sub>
<italic>C</italic>O), 137.5, 137.2, 128.5, 128.4, 128.3, 128.0, 127.9, 127.5 (Ar), 99.7 (C-1<sup>B</sup>), 97.2 (C-1<sup>A</sup>), 79.2 (C-3<sup>A</sup>), 76.5 (C-2<sup>A</sup>), 75.8 (C-3<sup>B</sup>), 72.6, 71.5 (2 Ph<italic>C</italic>H<sub>2</sub>), 67.9 (C-5<sup>B</sup>), 67.6 (C-5<sup>A</sup>), 67.4 (C-2<sup>B</sup>), 65.7 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 64.2 (C-4<sup>A</sup>), 63.8 (C-4<sup>B</sup>), 37.9 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.4 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 20.9 (<italic>C</italic>H<sub>3</sub>CO), 18.6 (C-6<sup>B</sup>), 18.5 (C-6<sup>A</sup>). HRMS (ESI): calcd. for C<sub>33</sub>H<sub>40</sub>F<sub>3</sub>N<sub>7</sub>O<sub>9</sub> [M + Na]<sup>+</sup>
<italic>m/z</italic> 758.2732; found <italic>m/z</italic> 758.2732.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranoside (21)</bold>. 1 M sodium methoxide (25&#xA0;&#x3BC;L) was added to a solution of compound 20 (77&#xA0;mg, 0.105&#xA0;mmol) in MeOH (2.5&#xA0;mL), and the mixture was stirred for 3&#xA0;h at room temperature. The solution was made neutral by adding Amberlite IR-120 (H<sup>+</sup>), the resin was filtered off and washed with MeOH (4 &#xD7; 4&#xA0;mL). The filtrate was evaporated, and the residue was subjected to column chromatography (toluene&#x2013;EtOAc, 15&#x2192;25%) to give deacetylated product <bold>21</bold> (70&#xA0;mg, 96%) as a colorless syrup, [&#x3B1;]<sub>D</sub> +89 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600&#xA0;MHz, CDCl<sub>3</sub>): &#x3B4; 7.43&#x2013;7.32 (m, 10 H, Ar), 6.60 (br. s, 1 H, NHCOCF<sub>3</sub>), 5.09 (s, 1 H, H-1<sup>B</sup>), 4.80 (s, 1 H, H-1<sup>A</sup>), 4.70 (d, 1 H, <italic>J</italic> = 11.6 Hz, PhC<italic>Ha</italic>Hb), 4.68 (d, 1 H, <italic>J</italic> = 11.6 Hz, PhCHa<italic>Hb</italic>), 4.67 (d, 1 H, <italic>J</italic> = 11.6 Hz, PhC<italic>Ha</italic>Hb&#x2032;), 4.60 (d, 1 H, <italic>J</italic> = 11.6 Hz, PhCHa<italic>Hb</italic>&#x2032;), 4.19 (br. s, 1 H, H-2<sup>B</sup>), 3.84 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, <italic>J</italic>
<sub>3,4</sub> = 10.0 Hz, H-3<sup>A</sup>), 3.79&#x2013;3.74 (m, 2 H, H-3<sup>B</sup>, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.72 (br. s, 1 H, H-2<sup>A</sup>), 3.68 (dq, 1 H, <italic>J</italic>
<sub>4,5</sub> = 10.0 Hz, <italic>J</italic>
<sub>5,6</sub> = 6.3 Hz, H-5<sup>B</sup>), 3.60 (t, 1 H, <italic>J</italic> = 10.2 Hz, H-4<sup>A</sup>), 3.52&#x2013;3.40 (m, 5 H, H-4<sup>B</sup>, H-5<sup>A</sup>, OCHa<italic>Hb</italic>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 2.49 (s, 1 H, OH), 1.89&#x2013;1.84 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.35 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6<sup>A</sup>), 1.28 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6<sup>B</sup>). <sup>13</sup>C NMR (150&#xA0;MHz, CDCl<sub>3</sub>): &#x3B4; 137.5, 137.2, 128.6, 128.5, 128.2, 128.1, 128.0, 127.5 (Ar), 101.4 (C-1<sup>B</sup>), 97.2 (C-1<sup>A</sup>), 78.9 (C-3<sup>A</sup>), 78.0 (C-3<sup>B</sup>), 76.8 (C-2<sup>A</sup>), 72.6, 71.9 (2 Ph<italic>C</italic>H<sub>2</sub>), 67.5 (&#xD7;2) (C-5<sup>A</sup>, C-5<sup>B</sup>), 67.2 (C-2<sup>B</sup>), 65.7 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 64.3 (C-4<sup>A</sup>), 63.7 (C-4<sup>B</sup>), 37.9 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.4 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 18.5 (&#xD7;2) (C-6<sup>A</sup>, C-6<sup>B</sup>). HRMS (ESI): calcd. for C<sub>31</sub>H<sub>38</sub>F<sub>3</sub>N<sub>7</sub>O<sub>8</sub> [M + Na]<sup>+</sup>
<italic>m/z</italic> 716.2626; found <italic>m/z</italic> 716.2628.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 2-<italic>O</italic>-acetyl-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranoside (22)</bold>. Mol. sieve 4&#xA0;&#xC5; (500&#xA0;mg) was added to a solution of imidate <bold>14</bold> (150&#xA0;mg, 0.32&#xA0;mmol) and acceptor <bold>21</bold> (195&#xA0;mg, 0.28&#xA0;mmol) in DCM (5&#xA0;mL), the resulting mixture was stirred for 1&#xA0;h at room temperature, and then cooled to &#x2212;40&#xB0;C. TMSOTf (11.6&#xA0;&#x3BC;L, 0.064&#xA0;mmol) was added, and the mixture was stirred for 1&#xA0;h with gradual increasing the temperature to &#x2212;10&#xB0;C, after which the reaction was quenched with Et<sub>3</sub>N (20&#xA0;&#x3BC;L). The mixture was diluted with chloroform (10&#xA0;mL), and the solids were filtered off and washed with chloroform (4 &#xD7; 4&#xA0;mL). The filtrate was washed with 1 M HCl (20&#xA0;mL) and water (30&#xA0;mL), and the solvent was evaporated. The residue was purified by column chromatography (petroleum ether&#x2013;EtOAc, 20&#x2192;30%) to yield trisaccharide <bold>22</bold> (260&#xA0;mg, 93%) as a colorless foam, [&#x3B1;]<sub>D</sub> +70 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): &#x3B4; 7.40&#x2013;7.27 (m, 15 H, Ar), 6.55 (poorly resolved t, 1 H, NHCOCF<sub>3</sub>), 5.44 (br. s, 1 H, H-2<sup>C</sup>), 5.00 (s, 1 H, H-1<sup>B</sup>), 4.92 (s, 1 H, H-1<sup>C</sup>), 4.79 (s, 1 H, H-1<sup>A</sup>), 4.74 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhC<italic>Ha</italic>Hb), 4.68 (d, 1 H, <italic>J</italic> = 11.6 Hz, PhC<italic>Ha</italic>Hb&#x2032;), 4.65 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhC<italic>Ha</italic>Hb&#x2032;&#x2032;), 4.64 (d, 1 H, <italic>J</italic> = 11.6 Hz, PhCHa<italic>Hb</italic>&#x2032;), 4.60 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhCHa<italic>Hb</italic>&#x2032;&#x2032;), 4.55 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhCHa<italic>Hb</italic>), 4.07 (br. s, 1 H, H-2<sup>B</sup>), 3.81&#x2013;3.74 (m, 4 H, H-3<sup>A</sup>, H-3<sup>B</sup>, H-3<sup>C</sup>, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.65 (br. s, 1 H, H-2<sup>A</sup>), 3.62&#x2013;3.54 (m, 3 H, H-4<sup>A</sup>, H-5<sup>B</sup>, H-5<sup>C</sup>), 3.53&#x2013;3.40 (m, 5 H, H-4<sup>C</sup>, H-5<sup>A</sup>, OCHa<italic>Hb</italic>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 3.38 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4<sup>B</sup>), 2.10 (s, 3 H, CH<sub>3</sub>CO), 1.89&#x2013;1.84 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.35 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6<sup>A</sup>), 1.33 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>C</sup>), 1.26 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>B</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 169.8 (CH<sub>3</sub>
<italic>C</italic>O), 137.4, 137.1, 128.6, 128.5, 128.4, 128.0, 127.9, 127.6 (Ar), 101.0 (C-1<sup>B</sup>), 99.3 (C-1<sup>C</sup>), 97.4 (C-1<sup>A</sup>), 78.2 (C-3<sup>A</sup>), 77.4 (C-3<sup>B</sup>), 76.7 (C-2<sup>A</sup>), 75.4 (C-3<sup>C</sup>), 73.2 (C-2<sup>B</sup>), 72.7, 71.9, 71.6 (3 Ph<italic>C</italic>H<sub>2</sub>), 68.0 (C-5<sup>B</sup>), 67.7 (C-5<sup>C</sup>), 67.6 (C-5<sup>A</sup>), 67.1 (C-2<sup>C</sup>), 65.7 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 64.7 (C-4<sup>A</sup>), 63.8 (&#xD7;2) (C-4<sup>B</sup>, C-4<sup>C</sup>), 37.8 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.4 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 18.6, 18.5, 18.4 (C-6<sup>A</sup>, C-6<sup>B</sup>, C-6<sup>C</sup>). HRMS (ESI): calcd. for C<sub>46</sub>H<sub>55</sub>F<sub>3</sub>N<sub>10</sub>O<sub>12</sub> [M + Na]<sup>+</sup>
<italic>m/z</italic> 1019.3845; found <italic>m/z</italic> 1019.3846.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranoside (23)</bold>. 1 M sodium methoxide (70&#xA0;&#x3BC;L) was added to a solution of compound <bold>22</bold> (347&#xA0;mg, 0.348&#xA0;mmol) in MeOH (7&#xA0;mL). After being stirred for 4&#xA0;h at room temperature, the mixture was made neutral with Amberlite IR-120 (H<sup>+</sup>) and the resin was filtered off and washed with MeOH (4 &#xD7; 4&#xA0;mL). The filtrate was concentrated, and the residue was purified by column chromatography (toluene&#x2013;EtOAc, 10&#x2192;20%) to afford deacetylated trisaccharide <bold>23</bold> (306&#xA0;mg, 92%) as a colorless foam, [&#x3B1;]<sub>D</sub> +86 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): &#x3B4; 7.43-7.30 (m, 15 H, Ar), 6.58 (poorly resolved t, 1 H, NHCOCF<sub>3</sub>), 5.03 (s, 1 H, H-1<sup>B</sup>), 5.01 (s, 1 H, H-1<sup>C</sup>), 4.79 (s, 1 H, H-1<sup>A</sup>), 4.74 (d, 1 H, <italic>J</italic> = 11.2 Hz, PhC<italic>Ha</italic>Hb), 4.70 (d, 1 H, <italic>J</italic> = 11.2 Hz, PhCHa<italic>Hb</italic>), 4.65 (s, 2 H, PhC<italic>H</italic>
<sub>
<italic>2</italic>
</sub>&#x2032;), 4.65 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhC<italic>Ha</italic>Hb&#x2032;&#x2032;), 4.61 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhCHa<italic>Hb</italic>&#x2032;&#x2032;), 4.12 (br. s, 1 H, H-2<sup>B</sup>), 4.01 (s, 1 H, H-2<sup>C</sup>), 3.81&#x2013;3.74 (m, 3 H, H-3<sup>A</sup>, H-3<sup>B</sup>, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.73 (dd, 1 H, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.8 Hz, H-3<sup>C</sup>), 3.66 (br. s, 1 H, H-2<sup>A</sup>), 3.64&#x2013;3.55 (m, 3 H, H-4<sup>A</sup>, H-5<sup>B</sup>, H-5<sup>C</sup>), 3.54&#x2013;3.40 (m, 5 H, H-4<sup>C</sup>, H-5<sup>A</sup>, OCHa<italic>Hb</italic>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 3.36 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4<sup>B</sup>), 2.35 (br. s, 1 H, OH), 1.90&#x2013;1.84 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.36 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>A</sup>), 1.34 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>C</sup>), 1.27 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6<sup>B</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 137.4, 137.3, 137.1, 128.6, 128.5, 128.3, 128.2, 128.0, 127.6 (Ar), 101.1 (C-1<sup>B</sup>), 100.7 (C-1<sup>C</sup>), 97.4 (C-1<sup>A</sup>), 78.2 (C-3<sup>A</sup>), 77.6 (C-3<sup>C</sup>), 77.5 (C-3<sup>B</sup>), 76.7 (C-2<sup>A</sup>), 73.2 (C-2<sup>B</sup>), 72.7, 72.0 (&#xD7;2) (3 Ph<italic>C</italic>H<sub>2</sub>), 67.9 (C-5<sup>B</sup>), 67.6 (C-5<sup>A</sup>), 67.4 (C-5<sup>C</sup>), 67.1 (C-2<sup>C</sup>), 65.7 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 64.7 (C-4<sup>A</sup>), 64.0 (C-4<sup>B</sup>), 63.8 (C-4<sup>C</sup>), 37.9 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.4 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 18.6 (C-6<sup>B</sup>), 18.5 (C-6<sup>A</sup>), 18.3 (C-6<sup>C</sup>). HRMS (ESI): calcd. for C<sub>44</sub>H<sub>53</sub>F<sub>3</sub>N<sub>10</sub>O<sub>11</sub> [M + NH<sub>4</sub>]<sup>+</sup>
<italic>m/z</italic> 972.4186; found <italic>m/z</italic> 972.4170.</p>
        <p>
<bold>5-(<italic>tert</italic>-Butyl)-2-methylphenyl 2-<italic>O</italic>-acetyl-3,4-di-<italic>O</italic>-benzyl-1-thio-&#x3B1;,&#x3B2;-</bold>
<sc>
<bold>d</bold>
</sc>
<bold>-rhamnopyranoside (27).</bold> BF<sub>3</sub>&#xB7;Et<sub>2</sub>O (68&#xA0;&#x3BC;L, 0.55&#xA0;mmol) was added to a chilled (ice bath) solution of 1,2-diacetate <bold>27</bold> (195&#xA0;mg, 0.455&#xA0;mmol) and 5-(<italic>tert</italic>-butyl)-2-methylthiophenol in DCM (4&#xA0;mL). The mixture was stirred for 15&#xA0;min., then the cooling bath was removed and stirring was continued at room temperature for next 2&#xA0;h. The mixture was diluted with chloroform (30&#xA0;mL), washed with water (30&#xA0;mL) and saturated NaHCO<sub>3</sub> solution, and concentrated. Column chromatography of the residue (petroleum ether&#x2013;EtOAc, 0&#x2192;10%) produced an anomeric mixture (&#x3B1;:&#x3B2; ratio &#x223C;1.3:1) of thiglycosides <bold>27</bold> (219&#xA0;mg, 88%) as a colorless syrup. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): &#x3B4; 7.67&#x2013;7.13 (m, 30 H, Ar), 5.84 (d, 1H, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, H-2<sub>&#x3B2;</sub>), 5.68 (br. s, 1.3 H, H-2<sub>&#x3B1;</sub>), 5.37 (s, 1.3 H, H-1<sub>&#x3B1;</sub>), 4.97 (d, 1.3 H, <italic>J</italic> = 11.0 Hz, PhC<italic>Ha</italic>Hb<sub>&#x3B1;</sub>), 4.95 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhC<italic>Ha</italic>Hb<sub>&#x3B2;</sub>), 4.84 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhC<italic>Ha</italic>Hb<sub>&#x3B1;</sub>&#x2032;), 4.81 (s, 1 H, H-1<sub>&#x3B2;</sub>), 4.77 (d, 1.3 H, <italic>J</italic> = 11.2 Hz, PhC<italic>Ha</italic>Hb<sub>&#x3B1;</sub>&#x2032;), 4.67 (d, 1.3 H, <italic>J</italic> = 11.0 Hz, PhCHa<italic>Hb</italic>
<sub>&#x3B1;</sub>), 4.65 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhCHa<italic>Hb</italic>
<sub>&#x3B2;</sub>), 4.61 (d, 1.3 H, <italic>J</italic> = 11.2 Hz, PhCHa<italic>Hb</italic>
<sub>&#x3B1;</sub>&#x2032;), 4.53 (d, 1 H, <italic>J</italic> = 11.0 Hz, PhCHa<italic>Hb</italic>
<sub>&#x3B2;</sub>&#x2032;), 4.32 (dq, 1.3 H, <italic>J</italic>
<sub>4,5</sub> = 9.4 Hz, H-5<sub>&#x3B1;</sub>), 4.00 (dd, 1.3 H, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.4 Hz, H-3<sub>&#x3B1;</sub>), 3.68 (dd, 1 H, <italic>J</italic>
<sub>3,4</sub> = 8.7 Hz, H-3<sub>&#x3B2;</sub>), 3.55 (t, 1.3 H, <italic>J</italic> = 9.4 Hz, H-4<sub>&#x3B1;</sub>), 3.51 (t, 1 H, <italic>J</italic> = 9.2 Hz, H-4<sub>&#x3B2;</sub>), 3.49 (dq, 1 H, <italic>J</italic>
<sub>4,5</sub> = 9.2 Hz, H-5<sub>&#x3B2;</sub>), 2.42 (s, 4 H, C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>-Ar<sub>&#x3B1;</sub>), 2.39 (s, 3 H, C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>-Ar<sub>&#x3B2;</sub>), 2.28 (s, 3 H, CH<sub>3</sub>CO<sub>&#x3B2;</sub>), 2.18 (s, 4 H, CH<sub>3</sub>CO<sub>&#x3B1;</sub>), 1.49 (d, 3 H, <italic>J</italic>
<sub>5,6</sub> = 5.7 Hz, H-6<sub>&#x3B2;</sub>), 1.38 (d, 3 H, <italic>J</italic>
<sub>5,6</sub> = 6.1 Hz, H-6<sub>&#x3B1;</sub>), 1.33 (s, 21 H, C(CH<sub>3</sub>)<sub>3</sub>). ). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 170.4, 170.3 (CH<sub>3</sub>
<italic>C</italic>O), 149.7, 149.6, 138.4, 138.2, 137.7, 137.6, 136.7, 135.8, 133.2, 132.6, 130.0, 129.8, 128.4, 128.3, 128.1, 128.0, 127.8, 127.7, 125.0, 124.5 (Ar), 85.8 (C-1<sub>&#x3B1;</sub>), 84.8 (C-1<sub>&#x3B2;</sub>), 81.3 (C-3<sub>&#x3B2;</sub>), 80.2 (C-4<sub>&#x3B1;</sub>), 79.3 (C-4<sub>&#x3B2;</sub>), 78.5 (C-3<sub>&#x3B1;</sub>), 76.1 (C-5<sub>&#x3B2;</sub>), 75.5, 71.9, 71.8 (Ph<italic>C</italic>H<sub>2</sub>), 70.9 (C-2<sub>&#x3B1;</sub>), 70.7 (C-2<sub>&#x3B2;</sub>), 69.1 (C-5<sub>&#x3B1;</sub>), 31.3 (C(<italic>C</italic>H<sub>3</sub>)<sub>3</sub>), 21.1 (<italic>C</italic>H<sub>3</sub>CO<sub>&#x3B1;</sub>), 20.9 (<italic>C</italic>H<sub>3</sub>CO<sub>&#x3B2;</sub>), 20.2 (<italic>C</italic>H<sub>3</sub>-Ar), 18.3 (C-6<sub>&#x3B2;</sub>), 17.9 (C-6<sub>&#x3B1;</sub>). HRMS (ESI): calcd. for C<sub>33</sub>H<sub>40</sub>O<sub>5</sub>S [M + Na]<sup>+</sup>
<italic>m/z</italic> 571.2489; found <italic>m/z</italic> 571.2482.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 2-<italic>O</italic>-acetyl-3,4-di-<italic>O</italic>-benzyl-&#x3B1;-<sc>d</sc>-rhamnopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranoside (28)</bold>. A mixture of thiglycoside <bold>27</bold> (58&#xA0;mg, 0.106&#xA0;mmol), acceptor <bold>19</bold> (103&#xA0;mg, 0.085&#xA0;mmol) and vol. sieve 4&#xA0;&#xC5; (150&#xA0;mg) in DCM (3&#xA0;mL) was for 1 h at room temperature and then cooled to &#x2212;20&#xB0;C. NIS (48&#xA0;mg, 0.212&#xA0;mmol) and TMSOTf (3.8&#xA0;&#x3BC;L, 0.021&#xA0;mmol) were added, and stirring was continued for 1&#xA0;h at &#x2212;20&#xB0;C. The reaction was quenched with pyridine (20&#xA0;&#x3BC;L), the mixture was diluted with chloroform (10&#xA0;mL), and the solids were filtered off and washed with chloroform (4 &#xD7; 4&#xA0;mL). The filtrate was washed with 0.5 M Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (20&#xA0;mL) and water (30 mL), and concentrated. Column chromatography of the residue (toluene&#x2013;EtOAc, 8&#x2192;13%) produced pentasaccharide <bold>28</bold> (121&#xA0;mg, 90%) as a colorless foam, [&#x3B1;]<sub>D</sub> +49 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): &#x3B4; 7.42&#x2013;7.22 (m, 30 H, Ar), 6.66 (poorly resolved t, 1 H, NHCOCF<sub>3</sub>), 5.46 (br. s, 1 H, H-2<sup>E</sup>), 5.08 (s, 1 H, H-1<sup>B</sup>), 5.04 (s, 1 H, H-1<sup>D</sup>), 4.99 (s, 1 H, H-1<sup>C</sup>), 4.90 (d, 1 H, <italic>J</italic> = 10.8 Hz, benzylic H), 4.85 (s, 1 H, H-1<sup>E</sup>), 4.76-4.51 (m, 10 H, 9 benzylic H, H-1<sup>A</sup>), 4.23 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhC<italic>Ha</italic>Hb), 4.15 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhCHa<italic>Hb</italic>), 4.03 (br. s, 1 H, H-2<sup>C</sup>), 4.00 (br. s, 1 H, H-2<sup>A</sup>), 3.94&#x2013;3.90 (m, 2 H, H-2<sup>D</sup>, H-3<sup>E</sup>), 3.85 (dd, 1 H, <italic>J</italic>
<sub>3,2</sub> = 2.8 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.4 Hz, H-3<sup>B</sup>), 3.83&#x2013;3.78 (m, 1 H, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.78&#x2013;3.69 (m, 3 H, H-3<sup>A</sup>, H-3<sup>D</sup>, H-5<sup>E</sup>), 3.66 (dd, 1 H, <italic>J</italic>
<sub>3,2</sub> = 2.8 Hz, <italic>J</italic>
<sub>3,4</sub> = 10.0 Hz, H-3<sup>C</sup>), 3.61 (br. s, 1 H, H-2<sup>B</sup>), 3.59&#x2013;3.52 (m, 4 H, H-4<sup>B</sup>, H-5<sup>B</sup>, H-5<sup>D</sup>, OCH<sub>2</sub>CH<sub>2</sub>C<italic>Ha</italic>HbN), 3.51&#x2013;3.32 (m, 7 H, H-4<sup>A</sup>, H-4<sup>D</sup>, H-4<sup>E</sup>, H-5<sup>A</sup>, H-5<sup>C</sup>, OCHa<italic>Hb</italic>CH<sub>2</sub>CH<sub>2</sub>N, OCH<sub>2</sub>CH<sub>2</sub>CHa<italic>Hb</italic>N), 3.25 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4<sup>C</sup>), 2.14 (s, 3 H, CH<sub>3</sub>CO), 1.93&#x2013;1.88 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.36&#x2013;1.33 (m, 6 H, H-6<sup>A</sup>, H-6<sup>D</sup>), 1.31 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>B</sup>), 1.22 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6<sup>E</sup>), 1.17 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6<sup>C</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 169.9 (CH<sub>3</sub>
<italic>C</italic>O), 138.4, 137.0, 137.5, 137.3, 137.1, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 127.5 (Ar), 100.8 (C-1<sup>C</sup>), 100.5 (C-1<sup>D</sup>), 99.3 (&#x421;-1<sup>E</sup>), 99.1 (C-1<sup>A</sup>), 98.4 (C-1<sup>B</sup>), 79.9 (C-4<sup>E</sup>), 78.4 (C-3<sup>A</sup>), 77.5 (C-3<sup>E</sup>), 77.2 (C-3<sup>B</sup>), 77.1 (C-3<sup>C</sup>), 76.9 (C-3<sup>D</sup>), 76.2 (C-2<sup>B</sup>), 75.4 (Ph<italic>C</italic>H<sub>2</sub>), 72.8 (C-2<sup>A</sup>), 72.5 (Ph<italic>C</italic>H<sub>2</sub>), 71.9, 71.8 (&#xD7;2), 71.7 (4 Ph<italic>C</italic>H<sub>2</sub>), 68.8 (C-2<sup>E</sup>), 68.1, 67.9, 67.8 (C-5<sup>B</sup>, C-5<sup>C</sup>, C-5<sup>D</sup>), 67.5 (C-5<sup>A</sup>), 65.9 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 64.6 (C-4<sup>B</sup>), 64.4 (C-4<sup>A</sup>), 64.0, 63.9 (C-4<sup>C</sup>, C-4<sup>D</sup>), 38.1 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.4 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 21.1 (<italic>C</italic>H<sub>3</sub>CO), 18.0 (&#xD7;4) (C-6<sup>A</sup>, C-6<sup>B</sup>, C-6<sup>C</sup>, C-6<sup>D</sup>), 17.8 (C-6<sup>E</sup>). HRMS (ESI): calcd. for C<sub>79</sub>H<sub>92</sub>F<sub>3</sub>N<sub>13</sub>O<sub>19</sub> [M + NH<sub>4</sub>]<sup>+</sup>
<italic>m/z</italic> 1601.6923; found <italic>m/z</italic> 1601.6906.</p>
        <p>
<bold>3-Trifluoroacetamidopropyl 3,4-di-<italic>O</italic>-benzyl-&#x3B1;-<sc>d</sc>-rhamnopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4-azido-2-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4-azido-3-<italic>O</italic>-benzyl-4,6-dideoxy-&#x3B1;-<sc>d</sc>-mannopyranoside (29).</bold> 1 M sodium methoxide (20&#xA0;&#x3BC;L) was added to a solution of compound <bold>28</bold> (121&#xA0;mg, 0.076&#xA0;mmol) in MeOH (2&#xA0;mL). After being stirred for 4&#xA0;h at room temperature, the mixture was made neutral with Amberlite IR-120 (H<sup>+</sup>) and the resin was filtered off and washed with MeOH (4 &#xD7; 4&#xA0;mL). The filtrate was concentrated, and the residue was purified by column chromatography (toluene&#x2013;EtOAc, 8&#x2192;15%) to yield deacetylated pentasaccharide <bold>29</bold> (109&#xA0;mg, 92%) as a colorless foam, [&#x3B1;]<sub>D</sub> +59 (c 1, &#x421;HCl<sub>3</sub>). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): &#x3B4; 7.42&#x2013;7.23 (m, 30 H, Ar), 6.63 (br. s, 1 H, NHCOCF<sub>3</sub>), 5.08 (s, 1 H, H-1<sup>B</sup>), 5.05 (s, 1 H, H-1<sup>D</sup>), 5.00 (s, 1 H, H-1<sup>C</sup>), 4.97 (s, 1 H, H-1<sup>E</sup>), 4.88 (d, 1 H, <italic>J</italic> = 11.0 Hz, benzylic H), 4.75&#x2013;4.62 (m, 8 H, H-1<sup>A</sup>, 7 benzylic H), 4.57 (d, 1 H, <italic>J</italic> = 11.0 Hz, benzylic H), 4.54 (d, 1 H, <italic>J</italic> = 11.6 Hz, benzylic H), 4.24 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhC<italic>Ha</italic>Hb), 4.17 (d, 1 H, <italic>J</italic> = 11.8 Hz, PhCHa<italic>Hb</italic>), 4.06 (br. s, 1 H, H-2<sup>E</sup>), 4.03 (br. s, 1 H, H-2<sup>C</sup>), 4.00&#x2013;3.97 (m, 2 H, H-2<sup>A</sup>, H-2<sup>D</sup>), 3.87&#x2013;3.82 (m, 2 H, H-3<sup>B</sup>, H-3<sup>E</sup>), 3.82&#x2013;3.77 (m, 1 H, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.77&#x2013;3.69 (m, 3 H, H-3<sup>A</sup>, H-3<sup>D</sup>, H-5<sup>E</sup>), 3.67 (dd, 1 H, , <italic>J</italic>
<sub>3,2</sub> = 2.6 Hz, <italic>J</italic>
<sub>3,4</sub> = 9.8 Hz, H-3<sup>C</sup>), 3.61 (br. s, 1 H, H-2<sup>B</sup>), 3.58&#x2013;3.51 (m, 4 H, H-4<sup>B</sup>, H-5<sup>B</sup>, H-5<sup>D</sup>, OCH<sub>2</sub>CH<sub>2</sub>C<italic>Ha</italic>HbN), 3.51&#x2013;3.43 (m, 4 H, H-4<sup>E</sup>, H-5<sup>A</sup>, OCHa<italic>Hb</italic>CH<sub>2</sub>CH<sub>2</sub>N, OCH<sub>2</sub>CH<sub>2</sub>CHa<italic>Hb</italic>N), 3.40&#x2013;3.34 (m, 3 H, H-4<sup>A</sup>, H-4<sup>D</sup>, H-5<sup>C</sup>), 3.27 (t, 1 H, <italic>J</italic> = 9.8 Hz, H-4<sup>C</sup>), 2.40 (br. s, 1 H, OH), 1.94&#x2013;1.85 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.36-1.32 (m, 6 H, H-6<sup>A</sup>, H-6<sup>D</sup>), 1.31 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>B</sup>), 1.20 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>E</sup>), 1.17 (d, 3 H, <italic>J</italic>
<sub>6,5</sub> = 6.1 Hz, H-6<sup>C</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): &#x3B4; 138.4, 137.9, 137.4, 137.3, 137.2, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.8, 127.7, 127.5 (Ar), 100.8 (C-1<sup>C</sup>), 100.7 (&#xD7;2), (C-1<sup>D</sup>, C-1<sup>E</sup>), 99.1 (C-1<sup>A</sup>), 98.5 (C-1<sup>B</sup>), 79.9 (C-4<sup>E</sup>), 79.5 (C-3<sup>E</sup>), 78.4 (C-3<sup>A</sup>), 77.2 (C-3<sup>B</sup>), 77.1 (&#xD7;2) (C-3<sup>C</sup>, C-3<sup>D</sup>), 76.4 (&#x421;-2<sup>B</sup>), 75.4 (Ph<italic>C</italic>H<sub>2</sub>), 73.4 (C-2<sup>C</sup>), 73.2 (C-2<sup>D</sup>), 72.9 (C-2<sup>A</sup>), 72.5, 72.2, 72.1, 71.9, 71.8 (5 Ph<italic>C</italic>H<sub>2</sub>), 68.6 (C-2<sup>E</sup>), 68.1 (&#xD7;2), 67.9 (&#xD7;2) (C-5<sup>B</sup>, C-5<sup>C</sup>, C-5<sup>D</sup>, C-5<sup>E</sup>), 67.5 (C-5<sup>A</sup>), 65.9 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 64.6 (C-4<sup>B</sup>), 64.5 (C-4<sup>A</sup>), 64.2 (C-4<sup>D</sup>), 64.0 (C-4<sup>C</sup>), 38.1 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.4 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 18.5 (&#xD7;4) (C-6<sup>A</sup>, C-6<sup>B</sup>, C-6<sup>C</sup>, C-6<sup>D</sup>), 17.7 (C-6<sup>E</sup>). HRMS (ESI): calcd. for C<sub>77</sub>H<sub>90</sub>F<sub>3</sub>N<sub>13</sub>O<sub>18</sub> [M + NH<sub>4</sub>]<sup>+</sup>
<italic>m/z</italic> 1559.6817; found <italic>m/z</italic> 1559.6804.</p>
        <p>
<bold>3-Aminopropy 4,6-dideoxy-4-formamido-&#x3B1;-</bold>
<sc>
<bold>d</bold>
</sc>
<bold>-mannopyranosyl-(1</bold>&#x2192;<bold>3)-4,6-dideoxy-4-formamido-&#x3B1;-</bold>
<sc>
<bold>d</bold>
</sc>
<bold>-mannopyranoside (4).</bold> A mixture of diazide <bold>21</bold> (95&#xA0;mg, 0.137&#xA0;mmol) and Pd(OH)<sub>2</sub>/C (30&#xA0;mg) in MeOH was stirred in a hydrogen atmosphere at 35&#xB0;C for 1.5&#xA0;h. The catalyst was filtered off and washed with MeOH (4 &#xD7; 4&#xA0;mL), and the filtrate was concentrated. Column chromatography (DCM&#x2013;MeOH, 0&#x2192;8%) of the residue produced diamine <bold>24</bold> (71&#xA0;mg, 81%) as a colorless syrup. HRMS (ESI): calcd. for C<sub>31</sub>H<sub>42</sub>F<sub>3</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup>
<italic>m/z</italic> 642.2997; found <italic>m/z</italic> 642.2991.</p>
        <p>Formic acid (25.5&#xA0;&#x3BC;L, 0.663&#xA0;mmol) and DCC (69&#xA0;mg, 0.334&#xA0;mmol) were added to a solution of diamine <bold>24</bold> (71&#xA0;mg, 0.111&#xA0;mmol) in a mixture of DCM&#x2013;MeOH (9:1, 4&#xA0;mL). The mixture was stirred for 1&#xA0;h, the solvents were evaporated, and the residue was suspended in DCM (4&#xA0;mL). Dicyclohexylurea was filtered off and washed with DCM (3 &#xD7; 3&#xA0;mL), the filtrate was concentrated, and the residue was purified by column chromatography (DCM&#x2013;MeOH, 0&#x2192;7%) to give bis(formamide) <bold>25</bold> (68&#xA0;mg, 88%) as a white amorphous solid. HRMS (ESI): calcd. for C<sub>33</sub>H<sub>42</sub>F<sub>3</sub>N<sub>3</sub>O<sub>10</sub> [M + NH<sub>4</sub>]<sup>+</sup>
<italic>m/z</italic> 715.3161; found <italic>m/z</italic> 715.3167.</p>
        <p>A mixture of compound <bold>25</bold> (68&#xA0;mg, 0.097&#xA0;mmol) and Pd(OH)<sub>2</sub>/C (20&#xA0;mg) in MeOH (3&#xA0;mL) was stirred under hydrogen for 2&#xA0;h at room temperature. The catalyst was remove by filtration and washed with MeOH (4 &#xD7; 4&#xA0;mL), and the filtrate was concentrated. Column chromatography of the residue afforded triol <bold>26</bold> (46&#xA0;mg, 92%) as a white amorphous solid. HRMS (ESI): calcd. for C<sub>19</sub>H<sub>30</sub>F<sub>3</sub>N<sub>3</sub>O<sub>10</sub> [M + Na]<sup>+</sup>
<italic>m/z</italic> 540.1775; found <italic>m/z</italic> 540.1780.</p>
        <p>Ambersep 900 (OH<sup>&#x2212;</sup>) (3&#xA0;mL) was added to a solution of compound <bold>26</bold> (46&#xA0;mg, 0.089&#xA0;mmol) in 50% aqueous MeOH (2&#xA0;mL). The mixture was kept for 1&#xA0;h with periodic shaking, and then the resin was filtered off and washed with 50% aqueous MeOH (6 &#xD7; 3&#xA0;mL). The filtrate was concentrated and the residue was subjected to gel-permeation chromatography to give title compound <bold>4</bold> (36&#xA0;mg, 92%) as a white amorphous solid. The data of NMR and mass-spectra were identical to those described previously (<xref rid="B33" ref-type="bibr">Tsvetkov and Nifantiev, 2023</xref>).</p>
        <p>
<bold>3-Aminopropy 4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranoside (1).</bold> The title compound was synthesized in four steps from protected precursor <bold>19</bold> in total yield of 55% (for details see <xref rid="s10" ref-type="sec">Supplementary Material</xref>). A white fluffy solid; contained a non-stoichiometric amount (0.45&#xA0;equiv.) of AcOH; [&#x3B1;]<sub>D</sub> +55 (c 1, water). <sup>1</sup>H NMR (600&#xA0;MHz, D<sub>2</sub>O): &#x3B4; 8.24&#x2013;8.18 (m, 2.8 H, H<sub>
<italic>Z</italic>
</sub>CON), 8.06-7.99 (m, 1.2 H, H<sub>
<italic>E</italic>
</sub>CON), 5.11&#x2013;4.92 (m, 4 H, 4 H-1), 4.20&#x2013;3.77 (m, 15.8 H, 4 H-2, 4 H-3, 4 H-4<sub>
<italic>Z</italic>
</sub>, 4 H-5, C<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.61&#x2013;3.56 (m, 1 H, OCHa<italic>Hb</italic>CH<sub>2</sub>CH<sub>2</sub>N), 3.51&#x2013;3.35 (m, 1.2 H, 4 H-4<sub>
<italic>E</italic>
</sub>), 3.16&#x2013;3.07 (m, 2 H, OCH<sub>2</sub>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 2.02&#x2013;1.95 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.90 (s, &#x223C;1.4 H, CH<sub>3</sub>COOH), 1.30-1.21 (m, 12 H, 4 H-6). <sup>13</sup>C NMR (150 MHz, D<sub>2</sub>O): &#x3B4; 169.0, 168.9 (H<sub>
<italic>E</italic>
</sub>CON), 166.1, 165.8 (H<sub>
<italic>Z</italic>
</sub>CON), 103.5, 103.4, 103.1, 102.9, 101.9, 99.6 (4 C-1), 79.4, 79.2, 79.0, 78,7, 78.6, 78,4, 77.5 (C-2<sup>A</sup>, C-2<sup>C</sup>, C-3<sup>B</sup>), 70.1,70.0, 69.9, 69.6, 69.5, 69.2, 69.0, 68.9, 68.7, 68.6, 68.5, 68.3 (C-3<sup>A</sup>, C-5<sup>A</sup>, C-2<sup>B</sup>, C-5<sup>B</sup>, C-3<sup>C</sup>, C-5<sup>C</sup>, C-2<sup>D</sup>, C-3<sup>D</sup>, C-5<sup>D</sup>), 66.4 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 58.2, 58.0, 57.9, 56.7 (4 C-4<sub>
<italic>E</italic>
</sub>), 53.3, 53.1, 52.9, 52.2, 52.1 (4 C-4<sub>
<italic>Z</italic>
</sub>), 38.6 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 27.9 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 18.4, 18.2, 18.1, 18.0, 17.9 (4 C-6). HRMS (ESI): calcd. for C<sub>31</sub>H<sub>53</sub>N<sub>5</sub>O<sub>17</sub> [M + H]<sup>+</sup>
<italic>m/z</italic> 768.3509; found <italic>m/z</italic> 768.3510.</p>
        <p>
<bold>3-Aminopropyl 4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranoside (2).</bold> The title compound was obtained in four steps from protected progenitor <bold>17</bold> in total yield of 54% (for details see <xref rid="s10" ref-type="sec">Supplementary Material</xref>). A white fluffy solid; contained a non-stoichiometric amount (0.40&#xA0;equiv.) of AcOH; [&#x3B1;]<sub>D</sub> +60 (c 1, water). <sup>1</sup>H NMR (600&#xA0;MHz, D<sub>2</sub>O): &#x3B4; 8.23&#x2013;8.18 (m, 2.1 H, 3 H<sub>
<italic>Z</italic>
</sub>CON), 8.06&#x2013;8.01 (m, 0.9 H, 3 H<sub>
<italic>E</italic>
</sub>CON), 5.04-4.92 (m, 3 H, 3 H-1), 4.21&#x2013;3.79 (m, 12.1 H, 3 H-2, 3 H-3, 3 H-4<sub>
<italic>Z</italic>
</sub>, 3 H-5, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.61&#x2013;3.56 (m, 1 H, OCHa<italic>Hb</italic>CH<sub>2</sub>CH<sub>2</sub>N), 3.48 (t, 0.3 H, <italic>J</italic> = 10.1 Hz, H-4<sub>
<italic>E</italic>
</sub>), 3.43 (t, 0.3 H, <italic>J</italic> = 10.3 Hz, H-4<sub>
<italic>E</italic>
</sub>), 3.36 (t, 0.3 H, <italic>J</italic> = 10.5 Hz, H-4<sub>
<italic>E</italic>
</sub>), 3.17&#x2013;3.07 (m, 2 H, OCH<sub>2</sub>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 2.02&#x2013;1.95 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.91 (s, 1.2 H, 0.4 C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>COOH), 1.30&#x2013;1.21 (m, 9 H, 3 H-6). <sup>13</sup>C NMR (150 MHz, D<sub>2</sub>O): &#x3B4; 169.0, 168.9 (3 H<sub>
<italic>E</italic>
</sub>CON), 165.9, 165.8 (3 H<sub>
<italic>Z</italic>
</sub>CON), 103.4, 103.2, 103.1, 102.9 (C-1<sup>B</sup>, C-1<sup>C</sup>), 99.4 (C-1<sup>A</sup>), 78.8, 77.8, 77.5, 77.4 (C-2<sup>A</sup>, C-3<sup>B</sup>), 70.3, 70.0, 69.8, 69.7, 69.2, 69.1 69.0, 68.8, 68.7, 68.6, 68.2, (C-2<sup>B</sup>, C-2<sup>C</sup>, C-3<sup>A</sup>, C-3<sup>C</sup>, C-5<sup>A</sup>, C-5<sup>B</sup>, C-5<sup>C</sup>), 66.2 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 57.9, 57.7, 56.5 (C-4<sub>
<italic>E</italic>
</sub>
<sup>A</sup>, C-4<sub>
<italic>E</italic>
</sub>
<sup>B</sup>, C-4<sub>
<italic>E</italic>
</sub>
<sup>C</sup>), 53.1, 52.7, 51.6 (C-4<sub>
<italic>Z</italic>
</sub>
<sup>A</sup>, C-4<sub>
<italic>Z</italic>
</sub>
<sup>B</sup>, C-4<sub>
<italic>Z</italic>
</sub>
<sup>C</sup>), 38.4 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 27.7 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 24.3 (<italic>C</italic>H<sub>3</sub>COOH), 17.9, 17.7 (C-6<sup>A</sup>, C-6<sup>B</sup>, C-6<sup>C</sup>). HRMS (ESI): calcd. for C<sub>24</sub>H<sub>42</sub>N<sub>4</sub>O<sub>13</sub> [M + H]+ <italic>m/z</italic> 595.2821; found <italic>m/z</italic> 595.2819.</p>
        <p>
<bold>3-Aminopropyl 4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranoside (3).</bold> The title trisaccharide was synthesized in four steps from protected precursor <bold>23</bold> in overall yield of 52% (for details see <xref rid="s10" ref-type="sec">Supplementary Material</xref>). A white fluffy solid; contained a non-stoichiometric amount (0.35&#xA0;equiv.) of AcOH; [&#x3B1;]<sub>D</sub> +65 (c 1, water). <sup>1</sup>H NMR (600&#xA0;MHz, D<sub>2</sub>O): &#x3B4; 8.22&#x2013;8.19 (m, 2.2 H, 3 H<sub>
<italic>Z</italic>
</sub>CON), 8.05-8.01 (m, 0.8 H, 3 H<sub>
<italic>E</italic>
</sub>CON), 5.09&#x2013;4.98 (m, 2 H, 2 H-1), 4.83 (d, 1 H, <italic>J</italic>
<sub>1,2</sub> = 2.0 Hz, H-1), 4.15&#x2013;3.91 (m, 12.2 H, 3 H-2, 3 H-3, 3 H-4<sub>
<italic>Z</italic>
</sub>, 3 H-5, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.62&#x2013;3.57 (m, 1 H, OCHa<italic>Hb</italic>CH<sub>2</sub>CH<sub>2</sub>N), 3.46 (t, 0.25 H, <italic>J</italic> = 10.3 Hz, H-4<sub>
<italic>E</italic>
</sub>), 3.43-3.35 (m, 0.5 H, 2 H-4<sub>
<italic>E</italic>
</sub>), 3.17&#x2013;3.07 (m, 2 H, OCH<sub>2</sub>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 2.03-1.95 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.91 (s, &#x223C;1 H, 0.35 C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>COOH), 1.29&#x2013;1.20 (m, 9 H, 3 H-6). <sup>13</sup>C NMR (150 MHz, D<sub>2</sub>O): &#x3B4; 169.1, 169.0 (3 H<sub>
<italic>E</italic>
</sub>CON), 166.2, 166.1 165.9 (3 H<sub>
<italic>Z</italic>
</sub>CON), 103.6, 103.5, 103.1, 102.1, 102.0, 100.9, 100.8 (C-1<sup>A</sup>, C-1<sup>B</sup>, C-1<sup>C</sup>), 79.4, 79.3, 78.7, 78.3, 77.9 (C-3<sup>A</sup>, C-2<sup>B</sup>), 70.2, 70.0, 69.7, 69.5, 69.3, 69.2, 69.1, 69.0, 68.9, 68.7, 68.6, 68.5, 68.2, 68.1 (C-2<sup>A</sup>, C-5<sup>A</sup>, C-3<sup>B</sup>, C-5<sup>B</sup>, C-2<sup>C</sup>, C-3<sup>C</sup>, C-5<sup>C</sup>), 66.2 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 58.1, 57.9, 56.7 (C-4<sub>
<italic>E</italic>
</sub>
<sup>A</sup>, C-4<sub>
<italic>E</italic>
</sub>
<sup>B</sup>, C-4<sub>
<italic>E</italic>
</sub>
<sup>C</sup>), 53.1, 53.0, 52.4 (C-4<sub>
<italic>Z</italic>
</sub>
<sup>A</sup>, C-4<sub>
<italic>Z</italic>
</sub>
<sup>B</sup>, C-4<sub>
<italic>Z</italic>
</sub>
<sup>C</sup>), 38.6 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 27.9 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 24.4 (<italic>C</italic>H<sub>3</sub>COOH), 18.4, 18.3, 18.2, 18.0 (C-6<sup>A</sup>, C-6<sup>B</sup>, C-6<sup>C</sup>). HRMS (ESI): calcd. for C<sub>24</sub>H<sub>42</sub>N<sub>4</sub>O<sub>13</sub> [M + H]+ <italic>m/z</italic> 595.2821; found <italic>m/z</italic> 595.2815.</p>
        <p>
<bold>3-Aminopropyl 4,6-dideoxy-4-formamido-&#x3B1;-</bold>
<sc>
<bold>d</bold>
</sc>
<bold>-mannopyranoside (5).</bold> The title glycoside was synthesized in four steps from protected compound <bold>13</bold> in total yield of 57% (for details see <xref rid="s10" ref-type="sec">Supplementary Material</xref>). A colorless glassy solid; contained a non-stoichiometric amount (0.4&#xA0;equiv.) of AcOH; [&#x3B1;]<sub>D</sub> +42 (c 1, water). <sup>1</sup>H NMR (600&#xA0;MHz, D<sub>2</sub>O): &#x3B4; 8.19 (s, 0.7 H, H<sub>
<italic>Z</italic>
</sub>CON), 8.02 (s, 0.4 H, H<sub>
<italic>E</italic>
</sub>CON), 4.85&#x2013;4.84 (m, 1 H, H-1), 3.98 (dd, 0.3 H, <italic>J</italic>
<sub>2,1</sub> = 2.0 Hz, <italic>J</italic>
<sub>2,3</sub> = 3.2 Hz, H-2<sub>
<italic>E</italic>
</sub>), 3.96 (t, 0.7 H, <italic>J</italic> = 2.4 Hz, H-2<sub>
<italic>Z</italic>
</sub>), 3.91-3.77 (m, 3.7 H, H-3, H-4<sub>
<italic>Z</italic>
</sub>, H-5, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.62&#x2013;3.57 (m, 1 H, OCHa<italic>Hb</italic>CH<sub>2</sub>CH<sub>2</sub>N), 3.36 (t, 0.3 H, <italic>J</italic> = 10.1 Hz, H-4<sub>
<italic>E</italic>
</sub>), 3.17&#x2013;3.08 (m, 2 H, OCH<sub>2</sub>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 2.03&#x2013;1.95 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.90 (s, 1.2 H, CH<sub>3</sub>COO<sup>&#x2013;</sup>), 1.26 (d, 0.9 H, <italic>J</italic>
<sub>6,5</sub> = 6.4 Hz, H-6<sub>
<italic>E</italic>
</sub>), 1.22 (d, 2.1 H, <italic>J</italic>
<sub>6,5</sub> = 6.3 Hz, H-6<sub>
<italic>Z</italic>
</sub>). <sup>13</sup>C NMR (150 MHz, D<sub>2</sub>O): &#x3B4; 169.0 (H<sub>
<italic>E</italic>
</sub>CON), 166.1 (H<sub>
<italic>Z</italic>
</sub>CON), 100.9 (C-1), 70.3 (C-2), 69.2 (C-3), 68.5 (C-5<sub>
<italic>Z</italic>
</sub>), 68.2 (C-5<sub>
<italic>E</italic>
</sub>), 66.2 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 57.9 (C-4<sub>
<italic>E</italic>
</sub>), 53.2 (C-4<sub>
<italic>Z</italic>
</sub>), 38.7 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 27.8 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 18.0 (C-6<sub>
<italic>Z</italic>
</sub>), 17.9 (C-6<sub>
<italic>E</italic>
</sub>). HRMS (ESI): calcd. for C<sub>10</sub>H<sub>20</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>
<italic>m/z</italic> 249.1445; found <italic>m/z</italic> 249.1449.</p>
        <p>
<bold>3-Aminopropy &#x3B1;-<sc>d</sc>-rhamnopyranosyl-(1&#x2192;2)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;3)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranosyl-(1&#x2192;2)-4,6-dideoxy-4-formamido-&#x3B1;-<sc>d</sc>-mannopyranoside (6).</bold> The title pentasaccharide was obtained in four steps from protected precursor <bold>29</bold> in total yield of 45% (for details see <xref rid="s10" ref-type="sec">Supplementary Material</xref>). A white fluffy solid; contained a non-stoichiometric amount (0.35&#xA0;equiv.) of AcOH; [&#x3B1;]<sub>D</sub> +55 (c 1, water). <sup>1</sup>H NMR (600&#xA0;MHz, D<sub>2</sub>O): &#x3B4; 8.25&#x2013;8.19 (m, 2.9 H, 3 H<sub>
<italic>Z</italic>
</sub>CON), 8.07&#x2013;8.00 (m, 1.1 H, 3 H<sub>
<italic>E</italic>
</sub>CON), 5.19&#x2013;4.93 (m, 5 H, 5 H-1), 4.20-3.73 (m, 20 H, H, 5 H-2, 5 H-3, 4 H-4<sub>
<italic>Z</italic>
</sub>, H-4<sup>E</sup>, 5 H-5, OC<italic>Ha</italic>HbCH<sub>2</sub>CH<sub>2</sub>N), 3.62&#x2013;3.57 (m, 1 H, OCHa<italic>Hb</italic>CH<sub>2</sub>CH<sub>2</sub>N), 3.52&#x2013;3.39 (m, 1.1 H, 4 H-4<sub>
<italic>E</italic>
</sub>), 3.15&#x2013;3.06 (m, 2 H, OCH<sub>2</sub>CH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>N), 2.01&#x2013;1.95 (m, 2 H, OCH<sub>2</sub>C<italic>H</italic>
<sub>
<italic>2</italic>
</sub>CH<sub>2</sub>N), 1.91 (s, 1.4 H, C<italic>H</italic>
<sub>
<italic>3</italic>
</sub>COOH), 1.31&#x2013;1.22 (m, 15 H, 5 H-6). <sup>13</sup>C NMR (150 MHz, D<sub>2</sub>O): &#x3B4; 169.0, 168.9 (3 H<sub>
<italic>E</italic>
</sub>CON), 166.1, 165.7 (3 H<sub>
<italic>Z</italic>
</sub>CON), 103.3, 103.1, 103.0, 102.1, 102.0, 101.9, 101.7, 99.6 (5 C-1), 79.0, 78.8, 78.6, 78.2, 77.9, 77.6, 77.4 (C-2<sup>A</sup>, C-3<sup>B</sup>, C-2<sup>C</sup>, C-2<sup>D</sup>), 73.2, 71.4, 71.3, 70.4, 70.0, 69.9, 69.7, 69.5, 69.4, 68.9, 68.7, 68.4 (C-3<sup>A</sup>, C-5<sup>A</sup>, C-2<sup>B</sup>, C-5<sup>B</sup>, C-3<sup>C</sup>, C-5<sup>C</sup>, C-3<sup>D</sup>, C-5<sup>D</sup>, C-2<sup>E</sup>, C-3<sup>E</sup>, C-4<sup>E</sup>, C-5<sup>E</sup>), 66.4 (O<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 58.2, 58.1, 58.0, 56.6 (4 C-4<sub>
<italic>E</italic>
</sub>), 53.3, 53.2, 53.1, 52.2, 52.1 (4 C-4<sub>
<italic>Z</italic>
</sub>), 38.6 (OCH<sub>2</sub>CH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>N), 28.1 (OCH<sub>2</sub>
<italic>C</italic>H<sub>2</sub>CH<sub>2</sub>N), 18.5, 18.3, 18.1, 18.0, 17.9, 17.8 (5 C-6). HRMS (ESI): calcd. for C<sub>37</sub>H<sub>63</sub>N<sub>5</sub>O<sub>21</sub> [M + H]<sup>+</sup>
<italic>m/z</italic> 914.4088; found <italic>m/z</italic> 914.4089.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors are grateful to Dr. A. S. Dmitrenok and Dr. A. O. Chizhov for recording NMR and mass spectra of synthesized compounds, respectively.</p>
    </ack>
    <sec sec-type="data-availability" id="s5">
      <title>Data availability statement</title>
      <p>The original contributions presented in the study are included in the article/<xref rid="s10" ref-type="sec">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
    </sec>
    <sec id="s6">
      <title>Author contributions</title>
      <p>YT: Investigation, Writing&#x2013;original draft. TV: Investigation, Writing&#x2013;original draft. SE: Investigation, Writing&#x2013;original draft. OS: Writing&#x2013;original draft, Investigation. YK: Investigation, Writing&#x2013;original draft. VK: Investigation, Writing&#x2013;original draft. NN: Conceptualization, Funding acquisition, Writing&#x2013;original draft.</p>
    </sec>
    <sec sec-type="COI-statement" id="s8">
      <title>Conflict of interest</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
      <p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
    </sec>
    <sec sec-type="disclaimer" id="s9">
      <title>Publisher&#x2019;s note</title>
      <p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
    </sec>
    <sec id="s10">
      <title>Supplementary material</title>
      <p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2024.1424157/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fchem.2024.1424157/full#supplementary-material</ext-link>
</p>
      <supplementary-material id="SM1" position="float" content-type="local-data">
        <media xlink:href="DataSheet1.docx"/>
      </supplementary-material>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Argunov</surname><given-names>D. A.</given-names></name><name><surname>Krylov</surname><given-names>V. B.</given-names></name><name><surname>Nifantiev</surname><given-names>N. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Convergent synthesis of isomeric heterosaccharides related to the fragments of galactomannan from Aspergillus fumigatus</article-title>. <source>Org. Biomol. Chem.</source>
<volume>13</volume>, <fpage>3255</fpage>&#x2013;<lpage>3267</lpage>. <pub-id pub-id-type="doi">10.1039/c4ob02634a</pub-id>
<pub-id pub-id-type="pmid">25643073</pub-id>
</mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ariosa-Alvarez</surname><given-names>A.</given-names></name><name><surname>Arencibia-Mohar</surname><given-names>A.</given-names></name><name><surname>Madrazo-Alonso</surname><given-names>O.</given-names></name><name><surname>Garcia-Imia</surname><given-names>L.</given-names></name><name><surname>Sierra-Gonzalez</surname><given-names>G.</given-names></name><name><surname>Verez-Bencomo</surname><given-names>V.</given-names></name></person-group> (<year>1998</year>). <article-title>Synthesis of the Vibrio cholerae O1 ogawa and inaba terminal disaccharides with dioxolane-type spacers and their coupling to proteins</article-title>. <source>J. Carbohydr. Chem.</source>
<volume>17</volume>, <fpage>1307</fpage>&#x2013;<lpage>1320</lpage>. <pub-id pub-id-type="doi">10.1080/07328309808002355</pub-id>
</mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bock</surname><given-names>K.</given-names></name><name><surname>Pedersen</surname><given-names>C.</given-names></name></person-group> (<year>1974</year>). <article-title>A study of <sup>13</sup>CH coupling constants in hexopyranoses</article-title>. <source>J. Chem. Soc. Perkin Trans.</source>
<volume>2</volume>, <fpage>293</fpage>&#x2013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1039/P29740000293</pub-id>
</mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bundle</surname><given-names>D. R.</given-names></name><name><surname>Gerken</surname><given-names>M.</given-names></name><name><surname>Peters</surname><given-names>T.</given-names></name></person-group> (<year>1988</year>). <article-title>Synthesis of antigenic determinants of the Brucella A antigen, utilizing methyl 4-Azido-4,6-Dideoxy-&#x3B1;-D-Mannopyranoside efficiently derived from D-mannose</article-title>. <source>Carbohydr. Res.</source>
<volume>174</volume>, <fpage>239</fpage>&#x2013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/0008-6215(88)85094-8</pub-id>
<pub-id pub-id-type="pmid">2454158</pub-id>
</mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bundle</surname><given-names>D. R.</given-names></name><name><surname>McGiven</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Brucellosis: improved diagnostics and vaccine insights from synthetic glycans</article-title>. <source>Acc. Chem. Res.</source>
<volume>50</volume>, <fpage>2958</fpage>&#x2013;<lpage>2967</lpage>. <pub-id pub-id-type="doi">10.1021/acs.accounts.7b00445</pub-id>
<pub-id pub-id-type="pmid">29219305</pub-id>
</mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caroff</surname><given-names>M.</given-names></name><name><surname>Bundle</surname><given-names>D. R.</given-names></name><name><surname>Perry</surname><given-names>M. B.</given-names></name></person-group> (<year>1984</year>). <article-title>Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9</article-title>. <source>Eur. J. Biochem.</source>
<volume>139</volume>, <fpage>195</fpage>&#x2013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1984.tb07994.x</pub-id>
<pub-id pub-id-type="pmid">6199199</pub-id>
</mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duncombe</surname><given-names>L.</given-names></name><name><surname>Howells</surname><given-names>L.</given-names></name><name><surname>Haughey</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>A. V.</given-names></name><name><surname>Kaveh</surname><given-names>D.</given-names></name><name><surname>G&#x171;rbilek</surname><given-names>S. E.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>The tip of Brucella O-polysaccharide is a potent epitope in response to brucellosis infection and enables short synthetic antigens to Be superior diagnostic reagents</article-title>. <source>Microorganisms</source>
<volume>10</volume>, <fpage>708</fpage>. <pub-id pub-id-type="doi">10.3390/microorganisms10040708</pub-id>
<pub-id pub-id-type="pmid">35456759</pub-id>
</mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Franco</surname><given-names>M. P.</given-names></name><name><surname>Mulder</surname><given-names>M.</given-names></name><name><surname>Gilman</surname><given-names>R. H.</given-names></name><name><surname>Smits</surname><given-names>H. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Human brucellosis</article-title>. <source>Lancet Infect. Dis.</source>
<volume>7</volume>, <fpage>775</fpage>&#x2013;<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(07)70286-4</pub-id>
<pub-id pub-id-type="pmid">18045560</pub-id>
</mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ganesh</surname><given-names>V. N.</given-names></name><name><surname>Sadowska</surname><given-names>J. M.</given-names></name><name><surname>Sarkar</surname><given-names>S.</given-names></name><name><surname>Howells</surname><given-names>L.</given-names></name><name><surname>McGiven</surname><given-names>J.</given-names></name><name><surname>Bundle</surname><given-names>D. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Molecular recognition of Brucella A and M antigens dissected by synthetic oligosaccharide glycoconjugates leads to a disaccharide diagnostic for brucellosis</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>136</volume>, <fpage>16260</fpage>&#x2013;<lpage>16269</lpage>. <pub-id pub-id-type="doi">10.1021/ja5081184</pub-id>
<pub-id pub-id-type="pmid">25263136</pub-id>
</mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gening</surname><given-names>M. L.</given-names></name><name><surname>Kurbatova</surname><given-names>E. A.</given-names></name><name><surname>Tsvetkov</surname><given-names>Y. E.</given-names></name><name><surname>Nifantiev</surname><given-names>N. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Development of approaches to a third-generation carbohydrate-conjugate vaccine against<italic>Streptococcus pneumoniae</italic>: the search for optimal oligosaccharide ligands</article-title>. <source>Russ. Chem. Rev.</source>
<volume>84</volume>, <fpage>1100</fpage>&#x2013;<lpage>1113</lpage>. <pub-id pub-id-type="doi">10.1070/RCR4574</pub-id>
</mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Godfroid</surname><given-names>J.</given-names></name><name><surname>Nielsen</surname><given-names>K.</given-names></name><name><surname>Saegerman</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Diagnosis of brucellosis in livestock and wildlife</article-title>. <source>Croat. Med. J.</source>
<volume>51</volume>, <fpage>296</fpage>&#x2013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.3325/cmj.2010.51.296</pub-id>
<pub-id pub-id-type="pmid">20718082</pub-id>
</mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grant</surname><given-names>O. C.</given-names></name><name><surname>Smith</surname><given-names>H. M. K.</given-names></name><name><surname>Firsova</surname><given-names>D.</given-names></name><name><surname>Fadda</surname><given-names>E.</given-names></name><name><surname>Woods</surname><given-names>R. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Presentation, presentation, presentation! Molecular-level insight into linker effects on glycan array screening data</article-title>. <source>Glycobiology</source>
<volume>24</volume>, <fpage>17</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwt083</pub-id>
<pub-id pub-id-type="pmid">24056723</pub-id>
</mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guiard</surname><given-names>J.</given-names></name><name><surname>Paszkiewicz</surname><given-names>E.</given-names></name><name><surname>Sadowska</surname><given-names>J. M.</given-names></name><name><surname>Bundle</surname><given-names>D. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Design and synthesis of a universal antigen to detect brucellosis</article-title>. <source>Angew. Chem. Int. Ed.</source>
<volume>52</volume>, <fpage>7181</fpage>&#x2013;<lpage>7185</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201302303</pub-id>
</mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hou</surname><given-names>S.-j.</given-names></name><name><surname>Kova&#x10D;</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Enhanced stereoselectivity of &#x3B1;-mannosylation under thermodynamic control using trichloroacetimidates</article-title>. <source>Carbohydr. Res.</source>
<volume>345</volume>, <fpage>999</fpage>&#x2013;<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1016/j.carres.2010.03.025</pub-id>
<pub-id pub-id-type="pmid">20381793</pub-id>
</mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kazakova</surname><given-names>E. D.</given-names></name><name><surname>Yashunsky</surname><given-names>D. V.</given-names></name><name><surname>Krylov</surname><given-names>V. B.</given-names></name><name><surname>Bouchara</surname><given-names>J.-P.</given-names></name><name><surname>Cornet</surname><given-names>M.</given-names></name><name><surname>Valsecchi</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Biotinylated oligo-&#x3B1;-(1&#x2192;4)-D-galactosamines and their N-acetylated derivatives: &#x3B1;-stereoselective synthesis and immunology application</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>142</volume>, <fpage>1175</fpage>&#x2013;<lpage>1179</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.9b11703</pub-id>
<pub-id pub-id-type="pmid">31913631</pub-id>
</mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kochetkov</surname><given-names>N. K.</given-names></name><name><surname>Nifant&#x2019;ev</surname><given-names>N. E.</given-names></name><name><surname>Backinowsky</surname><given-names>L. V.</given-names></name></person-group> (<year>1987</year>). <article-title>Synthesis of the capsular polysaccharide of type 14</article-title>. <source>Tetrahedron</source>
<volume>43</volume>, <fpage>3109</fpage>&#x2013;<lpage>3121</lpage>. <pub-id pub-id-type="doi">10.1016/S0040-4020(01)86852-6</pub-id>
</mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Komarova</surname><given-names>B. K.</given-names></name><name><surname>Wong</surname><given-names>S. S.</given-names></name><name><surname>Orekhova</surname><given-names>M. V.</given-names></name><name><surname>Tsvetkov</surname><given-names>Y. E.</given-names></name><name><surname>Krylov</surname><given-names>V. B.</given-names></name><name><surname>Beauvais</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Chemical synthesis and application of biotinylated oligo-&#x3B1;-(1&#x2192;3)-D-glucosides to study the antibody and cytokine response against the cell wall &#x3B1;-(1&#x2192;3)-D-glucan of Aspergillus fumigatus</article-title>. <source>J. Org. Chem.</source>
<volume>83</volume>, <fpage>12965</fpage>&#x2013;<lpage>12976</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.8b01142</pub-id>
<pub-id pub-id-type="pmid">30277398</pub-id>
</mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krylov</surname><given-names>V. B.</given-names></name><name><surname>Solovev</surname><given-names>A. S.</given-names></name><name><surname>Argunov</surname><given-names>D. A.</given-names></name><name><surname>Latg&#xE9;</surname><given-names>J.-P.</given-names></name><name><surname>Nifantiev</surname><given-names>N. E.</given-names></name></person-group> (<year>2019</year>). <article-title>Reinvestigation of carbohydrate specificity of EB-A2 monoclonal antibody used in the immune detection of Aspergillus fumigatus galactomannan</article-title>. <source>Heliyon</source>
<volume>5</volume>, <fpage>e01173</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2019.e01173</pub-id>
<pub-id pub-id-type="pmid">30766929</pub-id>
</mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kubler-Kielb</surname><given-names>J.</given-names></name><name><surname>Vinogradov</surname><given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>Reinvestigation of the structure of Brucella O-antigens</article-title>. <source>Carbohydr. Res.</source>
<volume>378</volume>, <fpage>144</fpage>&#x2013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.carres.2013.03.021</pub-id>
<pub-id pub-id-type="pmid">23664729</pub-id>
</mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laverde</surname><given-names>D.</given-names></name><name><surname>Romero-Saavedra</surname><given-names>F.</given-names></name><name><surname>Argunov</surname><given-names>D. A.</given-names></name><name><surname>Enotarpi</surname><given-names>J.</given-names></name><name><surname>Krylov</surname><given-names>V. B.</given-names></name><name><surname>Kalfopoulou</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Synthetic oligomers mimicking capsular polysaccharide diheteroglycan are potential vaccine candidates against encapsulated enterococcal infections</article-title>. <source>ACS Infect. Dis.</source>
<volume>6</volume>, <fpage>1816</fpage>&#x2013;<lpage>1826</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.0c00063</pub-id>
<pub-id pub-id-type="pmid">32364376</pub-id>
</mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mandal</surname><given-names>S. S.</given-names></name><name><surname>Duncombe</surname><given-names>L.</given-names></name><name><surname>Ganesh</surname><given-names>N. V.</given-names></name><name><surname>Sarkar</surname><given-names>S.</given-names></name><name><surname>Howells</surname><given-names>L.</given-names></name><name><surname>Hogarth</surname><given-names>P. J.</given-names></name><etal/></person-group> (<year>2017a</year>). <article-title>Novel solutions for vaccines and diagnostics to combat brucellosis</article-title>. <source>ACS Cent. Sci.</source>
<volume>3</volume>, <fpage>224</fpage>&#x2013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.7b00019</pub-id>
<pub-id pub-id-type="pmid">28386600</pub-id>
</mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mandal</surname><given-names>S. S.</given-names></name><name><surname>Ganesh</surname><given-names>N. V.</given-names></name><name><surname>Sadowska</surname><given-names>J. M.</given-names></name><name><surname>Bundle</surname><given-names>D. R.</given-names></name></person-group> (<year>2017b</year>). <article-title>Synthetic glycoconjugates characterize the fine specificity of Brucella A and M monoclonal antibodies</article-title>. <source>Org. Biomol. Chem.</source>
<volume>15</volume>, <fpage>3874</fpage>&#x2013;<lpage>3883</lpage>. <pub-id pub-id-type="doi">10.1039/c7ob00445a</pub-id>
<pub-id pub-id-type="pmid">28317992</pub-id>
</mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McGiven</surname><given-names>J.</given-names></name><name><surname>Howells</surname><given-names>L.</given-names></name><name><surname>Duncombe</surname><given-names>L.</given-names></name><name><surname>Stack</surname><given-names>J.</given-names></name><name><surname>Ganesh</surname><given-names>N. V.</given-names></name><name><surname>Guiard</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Improved serodiagnosis of bovine brucellosis by novel synthetic oligosaccharide antigens representing the capping M epitope elements of Brucella O-polysaccharide</article-title>. <source>J. Clin. Microbiol.</source>
<volume>53</volume>, <fpage>1204</fpage>&#x2013;<lpage>1210</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.03185-14</pub-id>
<pub-id pub-id-type="pmid">25653412</pub-id>
</mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mogues</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Coburn</surname><given-names>J.</given-names></name><name><surname>Kuter</surname><given-names>D. J.</given-names></name></person-group> (<year>2005</year>). <article-title>IgG antibodies against bovine serum albumin in humans&#x2014;their prevalence and response to exposure to bovine serum albumin</article-title>. <source>J. Immunol. Methods</source>
<volume>300</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.jim.2005.01.022</pub-id>
<pub-id pub-id-type="pmid">15890355</pub-id>
</mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>M. M.</given-names></name><name><surname>Xu</surname><given-names>P.</given-names></name><name><surname>Stevens</surname><given-names>E. D.</given-names></name><name><surname>Kov&#xE1;&#x107;</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Towards the complete synthetic O-antigen of <italic>Vibrio cholerae</italic> O1, serotype inaba: improved synthesis of the conjugation-ready upstream terminal hexasaccharide determinant</article-title>. <source>RSC Adv.</source>
<volume>9</volume>, <fpage>36440</fpage>&#x2013;<lpage>36454</lpage>. <pub-id pub-id-type="doi">10.1039/c9ra08232h</pub-id>
<pub-id pub-id-type="pmid">33791092</pub-id>
</mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>K.</given-names></name></person-group> (<year>2002</year>). <article-title>Diagnosis of brucellosis by serology</article-title>. <source>Vet. Microbiol.</source>
<volume>90</volume>, <fpage>447</fpage>&#x2013;<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1135(02)00229-8</pub-id>
<pub-id pub-id-type="pmid">12414164</pub-id>
</mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perry</surname><given-names>M. B.</given-names></name><name><surname>Bundle</surname><given-names>D. R.</given-names></name></person-group> (<year>1990</year>). <article-title>Antigenic relationships of the lipopolysaccharides of Escherichia hermannii strains with those of <italic>Escherichia coli</italic> O157:H7, Brucella melitensis, and Brucella abortus</article-title>. <source>Infect. Immun.</source>
<volume>58</volume>, <fpage>1391</fpage>&#x2013;<lpage>1395</lpage>. <pub-id pub-id-type="doi">10.1128/iai.58.5.1391-1395.1990</pub-id>
<pub-id pub-id-type="pmid">1691146</pub-id>
</mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peters</surname><given-names>V.</given-names></name><name><surname>Brisson</surname><given-names>J.-R.</given-names></name><name><surname>Bundle</surname><given-names>D. R.</given-names></name></person-group> (<year>1990</year>). <article-title>Conformational analysis of key disaccharide components of Brucella A and M antigens</article-title>. <source>Can. J. Chem.</source>
<volume>68</volume>, <fpage>979</fpage>&#x2013;<lpage>988</lpage>. <pub-id pub-id-type="doi">10.1139/v90-154</pub-id>
</mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sj&#xF6;wall</surname><given-names>C.</given-names></name><name><surname>Kastbom</surname><given-names>A.</given-names></name><name><surname>Almroth</surname><given-names>G.</given-names></name><name><surname>Wetter&#xF6;</surname><given-names>J.</given-names></name><name><surname>Skogh</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Beware of antibodies to dietary proteins in &#x201C;antigen-specific&#x201D; immunoassays! Falsely positive anticytokine antibody tests due to reactivity with bovine serum albumin in rheumatoid arthritis (the Swedish TIRA project)</article-title>. <source>J. Rheumatol.</source>
<volume>38</volume>, <fpage>215</fpage>&#x2013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.3899/jrheum.100690</pub-id>
<pub-id pub-id-type="pmid">21041271</pub-id>
</mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Solovev</surname><given-names>A. S.</given-names></name><name><surname>Denisova</surname><given-names>E. M.</given-names></name><name><surname>Kurbatova</surname><given-names>E. A.</given-names></name><name><surname>Kutsevalova</surname><given-names>O. Y.</given-names></name><name><surname>Boronina</surname><given-names>L. G.</given-names></name><name><surname>Ageevets</surname><given-names>V. A.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Synthesis of methylphosphorylated oligomannosides structurally related to lipopolysaccharide O-antigens of <italic>Klebsiella pneumoniae</italic> serotype O3 and their application for detection of specific antibodies in rabbit and human sera</article-title>. <source>Org. Biomol. Chem.</source>
<volume>21</volume>, <fpage>8306</fpage>&#x2013;<lpage>8319</lpage>. <pub-id pub-id-type="doi">10.1039/d3ob01203d</pub-id>
<pub-id pub-id-type="pmid">37794804</pub-id>
</mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Temme</surname><given-names>J. S.</given-names></name><name><surname>Campbell</surname><given-names>C. T.</given-names></name><name><surname>Gildersleeve</surname><given-names>J. C.</given-names></name></person-group> (<year>2019</year>). <article-title>Factors contributing to variability of glycan microarray binding profiles</article-title>. <source>Faraday Discuss.</source>
<volume>219</volume>, <fpage>90</fpage>&#x2013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1039/c9fd00021f</pub-id>
<pub-id pub-id-type="pmid">31338503</pub-id>
</mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsvetkov</surname><given-names>Y. E.</given-names></name><name><surname>Backinowsky</surname><given-names>L. V.</given-names></name><name><surname>Kochetkov</surname><given-names>N. K.</given-names></name></person-group> (<year>1989</year>). <article-title>Synthesis of a common polysaccharide antigen of <italic>Pseudomonas aeruginosa</italic> as the 6-aminohexyl glycoside</article-title>. <source>Carbohydr. Res.</source>
<volume>193</volume>, <fpage>75</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/0008-6215(89)85108-0</pub-id>
<pub-id pub-id-type="pmid">2514983</pub-id>
</mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsvetkov</surname><given-names>Y. E.</given-names></name><name><surname>Nifantiev</surname><given-names>N. E.</given-names></name></person-group> (<year>2023</year>). <article-title>Synthesis of a spacer-armed disaccharide structurally related to the M antigenic fragment of Brucella O-polysaccharides</article-title>. <source>Russ. Chem. Bull.</source>
<volume>72</volume>, <fpage>2731</fpage>&#x2013;<lpage>2737</lpage>. <pub-id pub-id-type="doi">10.1007/s11172-023-4079-4</pub-id>
</mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wong</surname><given-names>S. S. W.</given-names></name><name><surname>Krylov</surname><given-names>V. B.</given-names></name><name><surname>Argunov</surname><given-names>D. A.</given-names></name><name><surname>Karelin</surname><given-names>A. A.</given-names></name><name><surname>Bouchara</surname><given-names>J.-P.</given-names></name><name><surname>Fontaine</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Potential of chemically synthesized oligosaccharides to define the carbohydrate moieties of the fungal cell wall responsible for the human immune response, using Aspergillus fumigatus galactomannan as a model</article-title>. <source>Ex. Aspergillus fumigatus Cell wall galactomannan. mSphere</source>
<volume>5</volume> (<issue>e5</issue>), <fpage>e00688</fpage>. <pub-id pub-id-type="doi">10.1128/mSphere.00688-19</pub-id>
</mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Gu</surname><given-names>G.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name></person-group> (<year>2015</year>). <article-title>Synthesis of a trisaccharide repeating unit of the O-antigen from burkholderia multivorans and its oligomers</article-title>. <source>Eur. J. Org. Chem.</source>
<volume>2015</volume>, <fpage>7075</fpage>&#x2013;<lpage>7085</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.201500964</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>